<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Oncotarget</journal-id>
<journal-id journal-id-type="iso-abbrev">Oncotarget</journal-id>
<journal-id journal-id-type="publisher-id">Oncotarget</journal-id>
<journal-id journal-id-type="publisher-id">ImpactJ</journal-id>
<journal-title-group>
<journal-title>Oncotarget</journal-title>
</journal-title-group>
<issn pub-type="epub">1949-2553</issn>
<publisher>
<publisher-name>Impact Journals LLC</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27183914</article-id>
<article-id pub-id-type="pmc">5217052</article-id>
<article-id pub-id-type="publisher-id">9281</article-id>
<article-id pub-id-type="doi">10.18632/oncotarget.9281</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Physiological and pathological implications of 5-hydroxymethylcytosine in diseases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Liang</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Fan</given-names>
</name>
<xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Liang</given-names>
</name>
<xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bi</surname>
<given-names>Chongwei</given-names>
</name>
<xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cai</surname>
<given-names>Benzhi</given-names>
</name>
<xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="A2">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="A1"><sup>1</sup> Department of Pharmacology, Harbin Medical University (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin, China</aff>
<aff id="A2"><sup>2</sup> Institute of Clinical Pharmacy and Medicine, Academics of Medical Sciences of Heilongjiang Province, Harbin, China</aff>
<author-notes>
<corresp id="cor1">
<bold>
<italic>Correspondence to:</italic>
</bold>
<italic>Benzhi Cai,</italic>
<email>caibz@ems.hrbmu.edu.cn</email>
</corresp>
</author-notes>
<pub-date pub-type="collection">
<day>26</day>
<month>7</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>10</day>
<month>5</month>
<year>2016</year>
</pub-date>
<volume>7</volume>
<issue>30</issue>
<fpage>48813</fpage>
<lpage>48831</lpage>
<history>
<date date-type="received">
<day>18</day>
<month>11</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>4</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: © 2016 Liang et al.</copyright-statement>
<copyright-year>2016</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<abstract>
<p>Gene expression is the prerequisite of proteins. Diverse stimuli result in alteration of gene expression profile by base substitution for quite a long time. However, during the past decades, accumulating studies proved that bases modification is involved in this process. CpG islands (CGIs) are DNA fragments enriched in CpG repeats which mostly locate in promoters. They are frequently modified, methylated in most conditions, thereby suggesting a role of methylation in profiling gene expression. DNA methylation occurs in many conditions, such as cancer, embryogenesis, nervous system diseases etc. Recently, 5-hydroxymethylcytosine (5hmC), the product of 5-methylcytosine (5mC) demethylation, is emerging as a novel demethylation marker in many disorders. Consistently, conversion of 5mC to 5hmC has been proved in many studies. Here, we reviewed recent studies concerning demethylation <italic>via</italic> 5hmC conversion in several conditions and progress of therapeutics-associated with it in clinic. We aimed to unveil its physiological and pathological significance in diseases and to provide insight into its clinical application potential.</p>
</abstract>
<kwd-group>
<kwd>5hmC</kwd>
<kwd>TET</kwd>
<kwd>methylation</kwd>
<kwd>embryogenesis</kwd>
<kwd>heart</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>INTRODUCTION</title>
<p>Epigenetics defines a group of nucleotides modification, such DNA methylation, microRNA interference etc, as well as histone change, such as histone acetylation, methylation, phosphorylation etc, which could switch gene expression on or off. Chemical modification rather than base substitution occurs within DNA bases during epigenetic modification. DNA methylation is one of the most widely studied epigenetic modifications, and the critical role of DNA methylation in various conditions has been largely illustrated [<xref ref-type="bibr" rid="R1">1</xref>–<xref ref-type="bibr" rid="R3">3</xref>]. This process is precisely regulated by several DNA methyltransferases (DNMTs) including DNMT1, DNMT3A and DNMT3B. These enzymes are committed to transferring a methyl group from S-adenosyl methionine (SAM) to the 5<sup>th</sup> carbon of the cytosine which results in methylation. DNMT1 is maintenance methyltransferase which functions to retaining methylation status after early embryonic phase [<xref ref-type="bibr" rid="R4">4</xref>]. DNMT3A/B is de novo methyltransferase which regulates methylation status during embryogenesis [<xref ref-type="bibr" rid="R5">5</xref>]. 5mC is one of the cytosine derivatives, and other derivatives include 5hmC, 5-formylcytosine (5fC) and 5-carboxycytosine (5caC). 5mC, the dominant methylated product, constitutes ~1% of all mammalian DNA bases [<xref ref-type="bibr" rid="R6">6</xref>]. 5hmC, the product of 5mC hydroxylation, is involved in methyl group elimination and supposed to be an essential demethylation intermediate [<xref ref-type="bibr" rid="R7">7</xref>, <xref ref-type="bibr" rid="R8">8</xref>]. 5mC hydroxylation is catalyzed by Fe (II)-and 2-oxoglutarate (2-OG)-dependent dioxygenase ten-eleven-translocation (TETs) [<xref ref-type="bibr" rid="R8">8</xref>–<xref ref-type="bibr" rid="R10">10</xref>] (Figure <xref ref-type="fig" rid="F1">1</xref>). It has been proved that DNA methylation frequently happens in repetitive DNA fragments enriched in CGIs of inter-and intra-genes, such as tumor suppressor genes (TSG). It suggests the potential correlation between methylation and diseases, and provides some new targets for diseases treatment [<xref ref-type="bibr" rid="R11">11</xref>–<xref ref-type="bibr" rid="R14">14</xref>]. Thus, demethylation via 5hmC conversion probably abrogates methylation, thus ameliorating diseases. Remarkably, some studies have identified that re-patterning of 5hmC profile did exist under diverse pathologic and/or physiologic conditions while 5hmC recovery could reverse them [<xref ref-type="bibr" rid="R15">15</xref>–<xref ref-type="bibr" rid="R19">19</xref>]. In this review, we mainly focus on demethylation via 5hmC conversion in cancer, embryogenesis, nervous system disorder as well as cardiovascular system, and attempt to uncover its role in poorly understood areas. Meanwhile, perspective of its clinical application is also discussed to present its fantastic future.</p>
<fig id="F1" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<title>Introduction and elimination of 5hmC</title>
<p>TCA: tricarboxylic acid; BER: base excision repair; SAM: S-Adenosylmethionine.</p>
</caption>
<graphic xlink:href="oncotarget-07-48813-g001"></graphic>
</fig>
</sec>
<sec id="s2">
<title>DEMETHYLATION VIA 5HMC CONVERSION IN CANCER</title>
<p>Cancer which is capable of invading other tissues refers to disease concerning abnormal cell growth and proliferation. Although a large body of studies have highlighted that lots of stimuli, genetic and environmental mainly, may contribute to carcinogenesis limited studies mention epigenetics [<xref ref-type="bibr" rid="R20">20</xref>–<xref ref-type="bibr" rid="R23">23</xref>]. Recently, considerable studies have suggested involvement of epigenetics in cancer [<xref ref-type="bibr" rid="R24">24</xref>–<xref ref-type="bibr" rid="R27">27</xref>]. Meanwhile, it was reported that diverse epigenetic modifications were implicated in carcinogenesis in which methylation plays a leading role. In most cancer studies, methylation dysregulation followed by gene silencing or activation often occurred in pivotal genes, such as TSGs and oncogenes [<xref ref-type="bibr" rid="R28">28</xref>–<xref ref-type="bibr" rid="R32">32</xref>]. Hence, demethylation of these sites perhaps eradicates cancer. 5hmC, the primary product of DNA demethylation, was firstly discovered in mammals by Penn NW et al in 1972 [<xref ref-type="bibr" rid="R33">33</xref>]. Then it was found implicated in carcinogenesis [<xref ref-type="bibr" rid="R34">34</xref>–<xref ref-type="bibr" rid="R37">37</xref>]. Global loss of 5hmC was observed in large numbers of cancer in which TETs dysregulation was detected conincidentally [<xref ref-type="bibr" rid="R33">33</xref>, <xref ref-type="bibr" rid="R38">38</xref>].</p>
<sec id="s2_1">
<title>1. Demethylation <italic>via</italic> 5hmC conversion in hematopoietic malignancies</title>
<sec id="s2_1_1">
<title>i. Leukemia</title>
<p>DNA or chromosomal abnormalities is able to induce leukemia. Oncogenes, TSGs and other genes frequently mutate in leukemia [<xref ref-type="bibr" rid="R39">39</xref>–<xref ref-type="bibr" rid="R41">41</xref>]. Meanwhile, aberrant rearrangement of chromosomes is also suggested a role in leukemia [<xref ref-type="bibr" rid="R42">42</xref>, <xref ref-type="bibr" rid="R43">43</xref>]. TET2 involvement in leukemia has been largely demonstrated. F Viguié et al manifested that gene encoding TET2 was rearranged and deleted in acute myeloid leukemia (AML). It may indicate impairment of 5mC hydroxylation and subsequent 5hmC reduction in several studies [<xref ref-type="bibr" rid="R18">18</xref>, <xref ref-type="bibr" rid="R44">44</xref>, <xref ref-type="bibr" rid="R45">45</xref>]. Because of the key role of TETs in demethylation, regulators of TETs are capable of regulating demethylation. Isocitrate dehydrogenase (IDH) is able to catalyze 2-OG production in citric cycle. IDH mutation disturbs catalytic activity of TETs by producing 2-HG instead of 2-OG, thus inducing hypermethylation in leukemic patients [<xref ref-type="bibr" rid="R45">45</xref>]. A clinical study revealed that leukemic patients with both TET and IDH mutation showed lower 5hmC compared with those without TET or IDH mutation. Meanwhile, they manifested patients with high 5hmC showed lower overall survival which indicated some other pathways might involve leukemia [<xref ref-type="bibr" rid="R46">46</xref>]. Recently, a study suggested that IDH2/R140Q mutation decreased demethylation <italic>via</italic> 5hmC conversion and increased expression of several differentiation-related genes accompanied with activation of Meis1-related hypoxia pathway in transgenic leukemic mice [<xref ref-type="bibr" rid="R47">47</xref>]. It indicates critical role of IDH2 in development and maintenance of AML stem cells and implication of environmental factors in leukemia. However, Sadudee Chotirat et al. concluded a subtle role of IDH mutation in preleukemic disorder which implies rare involvement of IDH in leukemia at the initial stage [<xref ref-type="bibr" rid="R48">48</xref>]. In addition, mutation of WT1, which binds to TET2 and cooperatively recruits to target site, was detected in interruption of DNA demethylation associated with TET2 in AML. It suggested the direct interaction between WT1 and demethylation mediated by TET2 and provided a novel therapeutic target [<xref ref-type="bibr" rid="R49">49</xref>–<xref ref-type="bibr" rid="R51">51</xref>]. Interestingly, another study showed that hypoxia was involved in decrease of DNMT and TET2/TET3 along with increase of demethylation and WT1 expression. Again, it incorporated environmental factors into conditions associated with demethylation [<xref ref-type="bibr" rid="R47">47</xref>, <xref ref-type="bibr" rid="R52">52</xref>]. Additionally, TETs were suggested to bind to and be regulated by CRL4<sup>VprBP</sup> which monoubiquitylated its partners and offered them access to chromatin [<xref ref-type="bibr" rid="R53">53</xref>].</p>
<p>In conclusion, accumulating regulators of TETs are being discovered and proved as potential targets in leukemia treatment. Besides, environmental implication in leukemia is also suggested. It proposes the notion that both epigenetic modification and environment are involved in leukemogenesis.</p>
<fig id="F2" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<title>Effect of 5hmC disturbance upon cancer</title>
<p>5hmC regulates cell cycle progress, apoptosis, differentiation, proliferation and development <italic>via</italic> their critical regulator like TSGs and oncogenes, Ebf1, Spib, Hoxa9, etc. Furthermore, 5hmC is implicated activation of Meis1-associated hypoxia pathway, RHOA-associated biological process as well as other pathways.</p>
</caption>
<graphic xlink:href="oncotarget-07-48813-g002"></graphic>
</fig>
</sec>
<sec id="s2_1_2">
<title>ii. Lymphoma</title>
<p>Lymphoma is lymphocyte-derived lymphatic tumor. It constitutes around 55% of all hematologic malignancies. Although diverse lymphocytes are involved in lymphoma, two main subtypes, T-cell and B-cell lymphomas are exclusively focused. In contrast to TETs disruption in other tumors, TETs disruption is closely associated with lymphoma [<xref ref-type="bibr" rid="R54">54</xref>, <xref ref-type="bibr" rid="R55">55</xref>].</p>
<p>Cyril Quivoron et al showed that TET2 mutation was involved in human B-cell and T-cell lymphoma [<xref ref-type="bibr" rid="R56">56</xref>]. Another study of genomic profiling in diffuse large B-cell lymphoma found TET2 mutation primarily correlated with hypermethylation of hematopoietic differentiation-and development-associated genes. Among these genes, only 11% were decreased and several tumor suppressors were included [<xref ref-type="bibr" rid="R57">57</xref>]. A large body of studies evidenced the key role of TET2 in most tumors and TET1 mutation was also suggested as tumor suppressor in B-cell lymphoma [<xref ref-type="bibr" rid="R54">54</xref>]. Lately, a study demonstrated that TET1 deletion was able to induce B-cell lymphoma. Gene sequencing showed that the mutation dominant in TET1-deleted mice was observed in non-Hodgkin B cell lymphoma (B-NHL). It indicated the crucial role of TET1 as tumor suppressor in B-NHL as well as a novel potential target for its treatment [<xref ref-type="bibr" rid="R58">58</xref>]. To date, these conclusions drawn from B-cell lymphoma studies provide more targets and improve prognosis of diseases.</p>
<p>T-cell lymphoma is associated with TETs as well [<xref ref-type="bibr" rid="R59">59</xref>–<xref ref-type="bibr" rid="R61">61</xref>]. In a study of human T-cell lymphoma, simultaneous mutation of TET2 and DNMT3A was detected and DNMT3A mutation precedes TET2 mutation. It indicated the role of DNMT3A in T-cell lymphoma at early stage [<xref ref-type="bibr" rid="R61">61</xref>]. Consistently, a case study showed that TET2 was mutated in most samples (~76% in cohort) along with mutation of other genes, such as IDH2 and DNMT3A [<xref ref-type="bibr" rid="R62">62</xref>]. Besides, mutation of RHOA was also found following TET2 mutation. It suggested that TET2 might regulate physiology-associated processes through demethylation [<xref ref-type="bibr" rid="R63">63</xref>].</p>
</sec>
<sec id="s2_1_3">
<title>iii. Myeloma</title>
<p>Myeloma constitutes ~14% of total hematologic malignancies. It is involved in multiple organs and tissues, such as head, bone, kidney, blood etc, and thus being designated as multiple myelomas (MMs). Methylation influences myeloma by suppressing TSGs, activating oncogenes or regulating other proliferation-and differentiation-associated genes [<xref ref-type="bibr" rid="R64">64</xref>–<xref ref-type="bibr" rid="R66">66</xref>]. Although methylation is widely involved in MMs, relationship between MMs and demethylation <italic>via</italic> 5hmC conversion is poorly studied. Tumor suppressors, miR-9-1 and miR-9-3, were showed to be re-activated by 5-aza-2′-deoxycytidine in MMs. This suggests a new participator of MMs pathogenesis [<xref ref-type="bibr" rid="R67">67</xref>]. DNMT3A was downregulated resulting from hypermethylation. It suggested methylation abnormality happened in MMs [<xref ref-type="bibr" rid="R68">68</xref>]. Thus, DNMT3A is nominated as a prognostic marker of MMs. Moreover, Xabier Agirre et al observed that different hypermethylated sites were showed in enhancers other than promoters. It implied genes downregulation was correlated with enhancers hypermethylation in MMs. Therefore, it enables us to focus on other elements of genes besides promoters [<xref ref-type="bibr" rid="R69">69</xref>]. Though there are few studies associated with MMs, studies of DNMTs-mediated methylation dysregulation forward the research on TETs in MMs.</p>
</sec>
</sec>
<sec id="s2_3">
<title>Demethylation <italic>via</italic> 5hmC conversion in alimentary system malignancies</title>
<p>Alimentary system consists of mouth, esophagus, stomach, intestine and their accessory organs including pancreas, liver and cholecyst. Rich blood vessels, body fluid transportation as well as environmental factors predispose alimentary system to malignancy. Hence, it is very important to unravel detailed mechanisms. Increasing importance of methylation manifested in cancers makes demethylation a novel way of anti-cancer.</p>
<sec id="s2_3_1">
<title>i. Esophageal cancer</title>
<p>Though esophagus is positioned as the initial portion of alimentary system, few studies mentioned interrelationship between demethylation <italic>via</italic> 5hmC conversion and esophageal cancer. Recently, Asuka Murata et al. showed that 5hmC was decreased in esophageal squamous cell carcinoma (ESCC), and this reduction was due to TET2 suppression. Meanwhile, a direct correlation between 5hmC and overall survival (OS) was also manifested in this study [<xref ref-type="bibr" rid="R70">70</xref>].</p>
</sec>
<sec id="s2_3_2">
<title>ii. Gastric cancer</title>
<p>Lots of studies highlighted that 5hmC loss in gastric cancer (GC) was associated with TET1 downregulation [<xref ref-type="bibr" rid="R71">71</xref>, <xref ref-type="bibr" rid="R72">72</xref>]. Accordingly, other studies identified that 5hmC was downregulated through decreasing TET1, not TET2 or TET3, and indicated low 5hmC as a poor diagnostic marker in GC [<xref ref-type="bibr" rid="R36">36</xref>, <xref ref-type="bibr" rid="R73">73</xref>]. As tumor suppressor, TET1 suppression in GC was attributed to promoter hypermethylation of TET1. It further verified the disturbance of DNA methylation in cancer [<xref ref-type="bibr" rid="R74">74</xref>]. Consistently, Fu et al. showed that TET1 functioned as tumor suppressor <italic>via</italic> TSGs activation and oncogenes inhibition [<xref ref-type="bibr" rid="R75">75</xref>]. Herein, 5hmC dysregulation due to disturbance of various TETs indicates that any TET is probably involved in demethylation of GC.</p>
</sec>
<sec id="s2_3_3">
<title>iii. Colorectal cancer</title>
<p>Demethylation <italic>via</italic> 5hmC conversion in colorectal cancer (CRC) is largely proposed and studied. Considerable decrease of 5hmC in CRC was detected, and thus suggesting demethylation disturbance is involved in CRC [<xref ref-type="bibr" rid="R76">76</xref>]. Keun Hur et al revealed that hypomethylation was capable of activating several oncogenes which were silenced by methylation in CRC [<xref ref-type="bibr" rid="R77">77</xref>]. Although TETs mutation in CRC is rarely studied, alteration of their methylation is frequently addressed. Norihisa Ichimura et al. demonstrated TET1 methylation could contribute to CRC, thus aiding in CRC diagnosis [<xref ref-type="bibr" rid="R78">78</xref>]. Another study confirmed TET1 was involved in cancer cells proliferation via WNT signal pathway. Meanwhile, it suggested TET1 as tumor suppressor in colon cancer [<xref ref-type="bibr" rid="R79">79</xref>]. Besides, Santiago Uribe-Lewis et al. demonstrated that promoters enriched in 5hmC in normal colon as well as targets of TET2 in CRC were resistant to hypermethylation while this process was not mediated by TET2. Thus, it indicated 5hmC could be a biomarker for proliferation of cancer cells in CRC [<xref ref-type="bibr" rid="R80">80</xref>]. Moreover, TET1 was increased by ROS resulting from 5-FU followed by induction of cancer drug resistance in CRC. It indicates involvement of ROS pathway in demethylation and drug resistance [<xref ref-type="bibr" rid="R81">81</xref>, <xref ref-type="bibr" rid="R82">82</xref>].</p>
</sec>
</sec>
<sec id="s2_4">
<title>3. Demethylation <italic>via</italic> 5hmC conversion in nervous system tumors</title>
<p>Tumors in nervous system include glioblastoma, glioma, astrocytoma etc. As demethylation implication in other cancers, it is also associated with nervous system tumors. A study in normal brain and brain tumor showed that 5hmC was decreased to 1.1-1.9% in brain tumor compared with 61.5% in normal brain. It indicated 5hmC could be a marker of brain cancer [<xref ref-type="bibr" rid="R83">83</xref>]. It was consistent with studies presented by Jin SG and Brent A Orr [<xref ref-type="bibr" rid="R84">84</xref>, <xref ref-type="bibr" rid="R85">85</xref>]. Meanwhile, the inverse relationship between 5hmC level and proliferation of brain tumor cells was concluded. It indicated the potential of 5hmC as a diagnosis marker of brain tumor. Mutant IDH1, which is profoundly related to methylome reconstruction of glioma, could produce 2-OG, and thus inhibiting TETs [<xref ref-type="bibr" rid="R86">86</xref>]. However, another study demonstrated that 5hmC loss was independent of IDH1 mutation but associated with nuclear exclusion of TETs [<xref ref-type="bibr" rid="R87">87</xref>, <xref ref-type="bibr" rid="R88">88</xref>]. Thereby, it pushed us back to track. Consistently, Hans A Kretzschmar et al observed 5hmC increased in IDH1 mutation-independent way in glioblastoma [<xref ref-type="bibr" rid="R89">89</xref>]. It also showed the inverse proportion of 5hmC and proliferation markers, Ki67 and H3S10p. This indicated involvement of demethylation in brain tumor cells proliferation and potential of 5hmC as tumor marker. Notwithstanding, Kraus TF et al demonstrated that 5hmC disturbance in brain tumor was not associated with TETs mutation while it might be related to disruption of gene expression or inhibition of related proteins [<xref ref-type="bibr" rid="R90">90</xref>].</p>
<p>In addition to these cancers, other cancers, like melanoma, hepatocellular carcinoma, breast cancer etc, were also highlighted to be associated with demethylation disturbance [<xref ref-type="bibr" rid="R91">91</xref>–<xref ref-type="bibr" rid="R94">94</xref>]. One or more TETs are likely involved in cancers followed by products change of target genes which are related to proliferation, differentiation, tumorigenesis, drug resistance etc. Interference with these pathways provides us more possibility to eradicate cancers. Meanwhile, more targets are in the pipeline. They inspire researchers to design more specific and potent therapies for cancers.</p>
</sec>
</sec>
<sec id="s3">
<title>DEMETHYLATION VIA 5HMC CONVERSION IN EMBRYOGENESIS</title>
<p>Embryogenesis is a quite sophisticated process composed of cell proliferation and differentiation at early embryonic stage. After fertilization, zygote cleaves on the 2<sup>nd</sup> day which will not stop until achieving a blastomere comprising 16 or 32 cells termed as morula. Subsequently, blastulation, which indicates several mitotic divisions making cells count to 128, occurs followed by blastula implantation, gastrulation and organogenesis in order. This is the so-called histological process of embryogenesis. However, how each cell is committed to the cell with specific functions, such as neuron, gland cell, and movement cell, is a totally different story. DNA imprinting is epigenetic modification of DNA existing in all somatic cells. It confers specific expression profile to individual cell followed by specific functions. It has been verified that DNA methylation is the major player in DNA imprinting [<xref ref-type="bibr" rid="R95">95</xref>, <xref ref-type="bibr" rid="R96">96</xref>]. The genome-wide demethylation and the following methylation recovery occur at pre-implantation stage in primordial germ cells (PGCs). Preparation of this process for cell totipotency retrieval has been proved, thus identifying the role of demethylation in normal embryogenesis and suggesting the role of eccentric demethylation in abnormal embryogenesis [<xref ref-type="bibr" rid="R97">97</xref>, <xref ref-type="bibr" rid="R98">98</xref>]. A large number of studies have showed that DNA methylation in embryogenesis was due to DNA methyltransferase, and demethylation was due to TETs [<xref ref-type="bibr" rid="R5">5</xref>, <xref ref-type="bibr" rid="R99">99</xref>–<xref ref-type="bibr" rid="R104">104</xref>].</p>
<sec id="s3_1">
<title>1. Demethylation <italic>via</italic> 5hmC conversion in pre-implantation reprogramming</title>
<p>During pre-implantation stage, cleaving zygote is demethylated after 6-8 hours of fertilization in paternal genome while several cell divisions in maternal genome. Thenceforth, cells undergo de novo methylation for gene expression profiling [<xref ref-type="bibr" rid="R95">95</xref>, <xref ref-type="bibr" rid="R97">97</xref>]. Thus, pre-implantation reprogramming <italic>via</italic> demethylation and methylation is especially essential for embryogenesis.</p>
<p>Several pathways are implicated in demethylation of early embryogenesis and PGCs [<xref ref-type="bibr" rid="R105">105</xref>, <xref ref-type="bibr" rid="R106">106</xref>]. 5mC conversion to 5hmC is considered as one genome-wide demethylation pathway in pre-implantation reprogramming, and several candidate demethylases are verified [<xref ref-type="bibr" rid="R96">96</xref>, <xref ref-type="bibr" rid="R107">107</xref>]. Recently, several studies showed that TETs further oxidize 5hmC, 5fmC and 5caC stepwise whose end-product can be converted to 5C by thymine DNA glycosylase (TDG) or replication-dependent dilution at early embryonic phase [<xref ref-type="bibr" rid="R8">8</xref>, <xref ref-type="bibr" rid="R108">108</xref>, <xref ref-type="bibr" rid="R109">109</xref>]. Shinsuke Ito et al revealed that TET1 played an important role in demethylation of mouse embryogenesis <italic>via</italic> 5hmC conversion. They observed that TET1 KO could induce differentiation preference. It indicated the role of TET1 in embryonic cells specification and maintenance [<xref ref-type="bibr" rid="R17">17</xref>]. Another study confirmed the role of TET1 in active DNA demethylation <italic>via</italic> 5hmC conversion in early porcine embryo. It also demonstrated that 5mC, not 5hmC, was involved in initial cell specification in blastocysts [<xref ref-type="bibr" rid="R104">104</xref>]. However, an <italic>in vivo</italic> study showed that TET1 KO did not influence multipotency and embryogenesis [<xref ref-type="bibr" rid="R110">110</xref>]. Thus, different models may result in different results. Raul Mostoslavsky et al illustrated that histone deacetylase sirtuin 6 (SIRT6) KO was capable of increasing 5hmC in TET-dependent way. This drew out an upstream regulator of TETs-mediated demethylation. Furthermore, it implies that other epigenetic modifications, such as histone acetylation, are implicated in genome-wide demethylation through mediating TETs [<xref ref-type="bibr" rid="R111">111</xref>]. Besides, Jinsuk Kang et al revealed that much loss of 5hmC and much gain of 5mC due to TET1/3 KO in embryo of eight-cell stage occurred along with altered gene expression which could produce holoprosencephaly phenotype [<xref ref-type="bibr" rid="R112">112</xref>]. Meelad M Dawlaty et al found that triple-knockout of TET1/2/3 was able to diminish 5hmC. This impaired ESC specification in both embryonic stem cells (ESCs) and embryoid bodies (EB) by promoter hypermethylation [<xref ref-type="bibr" rid="R113">113</xref>]. However, another study exhibited different methylation style of DNA imprinting region in TETs-deleted models. It suggested that DNA imprinting regions of various genes were differentially modulated by TET. Furthermore, irregular methylation of DNA imprinting regions after TETs deletion observed in ESC and EB suggested limited application of EB in epigenetic study of embryogenesis [<xref ref-type="bibr" rid="R114">114</xref>]. Additionally, a study concluded that PRDM4 was capable of accelerating active demethylation which is partially through TET1 and TET2 recruitment to target loci in ESCs. It implied existence of other participators in TETs-mediated demethylation [<xref ref-type="bibr" rid="R115">115</xref>]. Taken together, TETs-mediated demethylation is crucial for embryogenesis. The involvement of this demethylation pathway in developmental abnormalities just started. More targets and the detailed mechanisms are required to be fully demonstrated.</p>
</sec>
<sec id="s3_2">
<title>2. Demethylation <italic>via</italic> 5hmC conversion in PGC reprogramming</title>
<p>PGC is the second extragonadal source of gamete cells occurring at 8<sup>th</sup> day after gestation [<xref ref-type="bibr" rid="R116">116</xref>, <xref ref-type="bibr" rid="R117">117</xref>]. PGC, which is capable of being induced to pluripotent stem cells (PSCs), derives from epiblast before inner cell mass (ICM) generation [<xref ref-type="bibr" rid="R118">118</xref>, <xref ref-type="bibr" rid="R119">119</xref>]. Similar with pre-implantation, genome-wide DNA demethylation as well as methylation recovery occurs in PGC to obtain germ cell phenotype [<xref ref-type="bibr" rid="R120">120</xref>–<xref ref-type="bibr" rid="R122">122</xref>]. Genome demethylation is completed between E10.5 and E12.5 after gestation, and then the roles of multiple demethylases in PGC development are demonstrated [<xref ref-type="bibr" rid="R123">123</xref>, <xref ref-type="bibr" rid="R124">124</xref>].</p>
<p>Recently, a study demonstrated that elevated TET1/2 decreased methylation in PGC, and sites escaping from demethylation, which were proved to be repeated loci, such as intracisternal A-particle (IAP), were also showed [<xref ref-type="bibr" rid="R102">102</xref>]. Thus, similar mechanism mediated by TETs may prevail in PGC reprogramming. Another study suggested that 5mC and 5hmC were low during E8.5 and E9.5 before 5hmC increased. The fact 5hmC enriched at chromatin area in TET1-dependent way implied TETs might be implicated in other modifications [<xref ref-type="bibr" rid="R125">125</xref>]. John J Vincent et al illustrated that TET1/2-mediated demethylation was involved in late phase of demethylation rather than initial phase. It suggested TETs played different roles in different phases of PGC reprogramming [<xref ref-type="bibr" rid="R126">126</xref>]. Another study concluded that DNA demethylation was correlated with ssDNA break and base excision repair pathways. It exhibited the potential function of DNA demethylation in PGC development [<xref ref-type="bibr" rid="R127">127</xref>]. Meanwhile, a study in AID deficiency implied other partners might play some roles in PGC methylation [<xref ref-type="bibr" rid="R128">128</xref>]. Calvopina Joseph Hargan demonstrated that demethylation pathway in PGC which was replication-dependent was similar with ESCs [<xref ref-type="bibr" rid="R129">129</xref>]. Therefore, TETs-mediated demethylation in PGC reprogramming plays the crucial role as in ESCs. They are differentially implicated in various phases of PGC reprogramming and target diverse signal pathways in addition to demethylation. To date, our insight into the role of demethylation <italic>via</italic> 5hmC conversion in PGC reprogramming is limited, and further studies are required.</p>
</sec>
</sec>
<sec id="s4">
<title>DEMETHYLATION VIA 5HMC CONVERSION IN NERVOUS SYSTEM</title>
<p>Methylation is involved in nervous system while demethylation is less addressed [<xref ref-type="bibr" rid="R130">130</xref>–<xref ref-type="bibr" rid="R138">138</xref>]. However, milestone built by Skirmantas Kriaucionis, Shinsuke Ito and Mamta Tahiliani changes this situation [<xref ref-type="bibr" rid="R8">8</xref>, <xref ref-type="bibr" rid="R10">10</xref>, <xref ref-type="bibr" rid="R139">139</xref>]. From then on, accumulating studies showed that demethylation <italic>via</italic> 5hmC conversion was correlated with development and diseases in nervous system. Though 5hmC is abundant in brain for obscure reason, it drives researchers to explore its roles in nervous system.</p>
<sec id="s4_1">
<title>1. Demethylation <italic>via</italic> 5hmC conversion in nervous system development</title>
<p>5hmC, which constitutes 0.6% of all nucleotides in Purkinje neurons and 0.2% in granule cells, is involved in nervous system development [<xref ref-type="bibr" rid="R140">140</xref>]. It was showed that 8% CpG of all autosomal chromosomes contained 5hmC, and it mainly enriched in enhancers and exons [<xref ref-type="bibr" rid="R141">141</xref>]. Differential distribution of 5hmC in brain implied 5hmC was associated with neurodevelopment and disorders [<xref ref-type="bibr" rid="R142">142</xref>–<xref ref-type="bibr" rid="R144">144</xref>]. Keith E Szulwach et al demonstrated that dynamic shift of 5hmC occurred at different stages of neural cells. However, some sites were 5hmC-conservative. Besides, 5hmC was in inverse proportion with methyl-CpG-binding protein 2 which was Rett syndrome-associated protein [<xref ref-type="bibr" rid="R15">15</xref>]. It suggested 5hmC played roles in nervous system. Meanwhile, 5hmC was implicated in nervous system development in a positive correlation way. 5hmC enriched in exons and UTR while diminished in introns and intergenic regions. It was associated with autism [<xref ref-type="bibr" rid="R145">145</xref>]. Therefore, 5hmC does participate in nervous system development as well as nervous system diseases. Recently, Run-Rui Zhang et al demonstrated that TET1 KO could downregulate proliferation of neural progenitor cells followed by impairment of hippocampal neurogenesis in brain of adult mice which showed poor ability of learning and memory. They also detected increase of methylation and decrease of gene expression. These genes were correlated with proliferation of neural progenitor cells [<xref ref-type="bibr" rid="R146">146</xref>]. Particularly, a study detecting 5hmC among stem cells, neuronal progenitor cells and mature olfactory sensory neurons (mOSNs) found that 5hmC increased with development and was obviously abundant in mOSNs. Additionally, TET3 overexpression resulted in hypomethylation, increased gene expression as well as physiologic abnormality [<xref ref-type="bibr" rid="R147">147</xref>]. However, TET3 was showed to play a role in regulation of Dnmt3a and Dkk1 expression by demethylation, in neural stem cells [<xref ref-type="bibr" rid="R148">148</xref>]. Interestingly, Svetlana Dzitoyeva et al examined 5hmC in mitochondria of mouse frontal cortex and cerebellum at different ages. They found that aging was exclusively associated with 5hmC decrease while not with 5mC in frontal cortex. Moreover, mtDNMT1 was depleted while TET2/TET3 was unaffected in frontal cortex. Nonetheless, TET1/TET3 was elevated while mtDNMT1 was unaffected during aging in cerebellum [<xref ref-type="bibr" rid="R149">149</xref>]. Strikingly, an environmental study showed that vitamin C could induce neural stem cells to differentiate into another type of neurons related to Parkinson's disease. It was associated with increased 5hmC. Gene KO study suggested that it was mediated by TET1 [<xref ref-type="bibr" rid="R150">150</xref>]. This study, however, not only exhibited importance of demethylation in nervous system disorders, but emphasized effect of environmental factors on epigenetic modifications.</p>
</sec>
<sec id="s4_2">
<title>2. Demethylation <italic>via</italic> 5hmC conversion in other nervous system disorders</title>
<p>Besides nervous system development, demethylation via 5hmC conversion is emerging as a key epigenetic modification in other nervous disorders. 5hmC reduction was found in Huntington's disease (HD) which was mediated by several signal pathways associated with neural development and differentiation [<xref ref-type="bibr" rid="R151">151</xref>]. In Alzheimer's disease (AD), both 5mC and 5hmC were elevated along with differential distribution in various neural cells and increasing AD markers. It indicated targeting 5hmC could be applied in AD treatment [<xref ref-type="bibr" rid="R152">152</xref>]. Moreover, in Autism spectrum disorder (ASD), A Zhubi et al observed 5hmC enriched in promoter of methyl CpG binding protein-2 (MeCP2)-binding accompanied with TET1 enrichment and binding. They were able to facilitate MeCP2 binding and gene expression [<xref ref-type="bibr" rid="R153">153</xref>]. Furthermore, in prenatal stress, Erbo Dong et al. revealed that 5hmC enriched in promoter brain-derived neurotrophic factor (Bdnf) gene. This gene correlated with social behaviors. Thus, it implied a potential role of 5hmC in reducing Bdnf expression [<xref ref-type="bibr" rid="R154">154</xref>].</p>
<p>Overall, considerable studies showed the role of demethylation <italic>via</italic> 5hmC conversion in nervous system. Most of them clarified the involvement of TETs in this process while some did not. Therefore, more studies are required for its role in nervous system.</p>
</sec>
</sec>
<sec id="s5">
<title>DEMETHYLATION VIA 5HMC CONVERSION IN OTHER CONDITIONS</title>
<p>The particular fate of cardiomyocytes similar with neurons requires studies concentrating on demethylation in heart. Though 5hmC is very low in human heart, high 5hmC enrichment in repetitive elements and intergenic regions in cardiac hypertrophy compared with high 5hmC enrichment in gene bodies of normal heart suggests that 5hmC-mediated demethylation shifts under pathologic condition. It links heart dysfunction to demethylation [<xref ref-type="bibr" rid="R76">76</xref>, <xref ref-type="bibr" rid="R155">155</xref>]. Another study revealed that a large scale of 5hmC enriched in Notch pathway-related genes in skeletal muscle, heart, and cerebellum. This pathway was critical for stem cells [<xref ref-type="bibr" rid="R156">156</xref>]. Recently, a study in uterus showed that caffeine exposure could alter methylation patterning by interrupting both DNMTs and TETs. This alteration increased wall thickness and left ventricular mass [<xref ref-type="bibr" rid="R157">157</xref>]. Consistently, cardiac hypertrophy induced by cAMP was through similar mechanism [<xref ref-type="bibr" rid="R158">158</xref>]. Renjing Liu et al showed that TET2 was capable of regulating plasticity of smooth muscle cells (SMCs) and differentiation of fibroblasts towards SMCs while TET2-dependent 5hmC upregulation could mitigate intimal hyperplasia [<xref ref-type="bibr" rid="R159">159</xref>]. It showed a potential role of demethylation <italic>via</italic> 5hmC conversion mediated by TETs in differentiation of cardiovascular cells. Otherwise, arsenic, a drug closely correlated with heart dysfunction, was showed to be associated with demethylation in rat heart. It suggested a novel mechanism of arsenic in heart diseases [<xref ref-type="bibr" rid="R160">160</xref>–<xref ref-type="bibr" rid="R164">164</xref>]. These studies extend our insight into the roles of demethylation in cardiovascular system and suggest a bright future of demethylation in heart diseases treatment.</p>
<fig id="F3" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<title>Demethylation and remethylation in mouse early embryogenesis and PGC reprogramming</title>
<p>In pre-implantation reprogramming, demethylation initiates at 6h-8h after fertilization and is completed on E6 when implantation happens. Thereafter, remethylation initiates and completes around E9. Demethylation of PGC initiates on E10 and attains in 2 days while remethylation occurs at birth.</p>
</caption>
<graphic xlink:href="oncotarget-07-48813-g003"></graphic>
</fig>
</sec>
<sec id="s6">
<title>PHAMACOTHERAPEUTICS OF DEMETHYLATION IN DISEASES</title>
<p>The important role of demethylation in diseases indicates the promising perspective of demethylation therapy. In fact, several demethylation agents have been studied and applied as a strategy for diseases treatment, such as 5-azacitidine, decitabine, zebularine, clofarabine, fazarabine, MG98 etc [<xref ref-type="bibr" rid="R165">165</xref>]. As newly discovered demethylation enzymes, candidates intervening TETs are in the pipeline. However, stories happened to former demethylation agents may promise us its encouraging perspective.</p>
<sec id="s6_1">
<title>1. Demethylation agents targeting DNMTs</title>
<p>Different from TETs, DNMTs are important maintenance methyltransferase in mammalian cells. A lot of studies have showed that DNMTs imbalance occurs widely in various conditions and is closely linked to their abnormal methylation [<xref ref-type="bibr" rid="R166">166</xref>, <xref ref-type="bibr" rid="R167">167</xref>]. DNMTs inhibition induces DNA demethylation. Agents targeting DNMTs have presented remarkable role clinically [<xref ref-type="bibr" rid="R168">168</xref>, <xref ref-type="bibr" rid="R169">169</xref>, <xref ref-type="bibr" rid="R170">170</xref>]. Meanwhile, DNMTs themself can be a clinical predictor of disease stages [<xref ref-type="bibr" rid="R167">167</xref>].</p>
<fig id="F4" orientation="portrait" position="float">
<label>Figure 4</label>
<caption>
<title>Effects of 5hmC disturbance upon nervous system</title>
<p>5hmC is involved in various nervous system disorders <italic>via</italic> transcription dysregulation of a large pool of factors, and these factors play essential role in neural cellular differentiation, proliferation and development.</p>
</caption>
<graphic xlink:href="oncotarget-07-48813-g004"></graphic>
</fig>
<sec id="s6_1_1">
<title>i. Nucleoside analogues</title>
<p>Generally, the majority of DNMTs inhibitors are nucleoside analogues. These inhibitors can be incorporated into DNA or RNA followed by covalent bond formation with DNMTs and consequent inhibition [<xref ref-type="bibr" rid="R165">165</xref>]. Then, methylation profile will be altered in organisms.</p>
<p>5-azacitidine (5-AZA), one of cytidine analogues, has been approved by FDA as a drug mainly for MDS treatment in 2004. The approval summary reported that 5-AZA was able to improve prognosis of MDS patients by eliminating the transfusion dependence and normalization of blood cells as well as bone marrow morphology [<xref ref-type="bibr" rid="R171">171</xref>]. Notably, a recent clinic study demonstrated that 5-AZA showed effect in AML treatment [<xref ref-type="bibr" rid="R172">172</xref>]. This study evidenced that 5-AZA improved OS in contrast to conventional regimens. Furthermore, 5-AZA was more effective for patients with cytogenetics and MDS alterations. Besides, substantial studies have suggested the role of 5-AZA in various cancers [<xref ref-type="bibr" rid="R173">173</xref>, <xref ref-type="bibr" rid="R174">174</xref>, <xref ref-type="bibr" rid="R175">175</xref>]. Although demethylation activity of 5-AZA has been reported for quite a long time, its mechanism was considered to be mediated mainly through inhibiting RNA/DNA synthesis initially while its implication in DNMTs regulation was demonstrated later [<xref ref-type="bibr" rid="R176">176</xref>]. Decitabine, also called 5-aza-2′-deoxycytidine, is another analogue of cytidine which can be incorporated into DNA, and subsequently inhibiting DNMTs. Decitabine was approved as drug for MDS treatment by targeting DNMTs in 2006 [<xref ref-type="bibr" rid="R177">177</xref>]. A MDS patients study showed that patients receiving decitabine attained higher response rate, improved hematologic environment as well as longer interruption to deteriorative stages [<xref ref-type="bibr" rid="R178">178</xref>]. Similar with 5-AZA, decitabine shows effect in multiple diseases, such as AML, lymphoma, lung cancer etc [<xref ref-type="bibr" rid="R179">179</xref>, <xref ref-type="bibr" rid="R180">180</xref>, <xref ref-type="bibr" rid="R181">181</xref>]. Different from 5-AZA, decitabine is deoxynucleoside analogue which determines its exclusive role in DNA methylation. Thanks to 5-AZA and decitabine, zebularine, a new member of cytidine analogues, was synthesized aiming to provide a more effective and safer drug for cancer treatment. In addition to DNMT, zebularine also deactivates cytidine deaminase which is crucial for maintenance of pharmacologic activity of cytidine analogues, and thus improving its effect [<xref ref-type="bibr" rid="R182">182</xref>, <xref ref-type="bibr" rid="R183">183</xref>]. Interestingly, Cheng JC et al. found that not only did zebularine confer cells growth inhibition and silenced cancer-antigen genes re-expression to cancer cells, but also zebularine downregulated DNMT1 preferentially [<xref ref-type="bibr" rid="R184">184</xref>]. Also, zebularine functions in multiple conditions including immune diseases, cell differentiation etc [<xref ref-type="bibr" rid="R185">185</xref>, <xref ref-type="bibr" rid="R186">186</xref>].</p>
<p>Clofarabine, an adenosine analogue inspired from fludarabine and cladribine, is a FDA-approved drug for paediatric ALL in 2004 [<xref ref-type="bibr" rid="R187">187</xref>]. At first, mechanism of clofarabine effect is considered to be mediated mainly by three pathways: DNA polymerase inhibition, ribonucleotide reductase inhibition and apoptosis induction [<xref ref-type="bibr" rid="R188">188</xref>]. However, several recent studies manifested that clofarabine could demethylate cells at low concentration which subsequently induces re-expression of silenced genes in cancers [<xref ref-type="bibr" rid="R189">189</xref>, <xref ref-type="bibr" rid="R190">190</xref>]. These findings indicate demethylation may be the 4<sup>th</sup> pathway of clofarabine treatment in cancers which may be independent of DNMTs.</p>
</sec>
<sec id="s6_1_2">
<title>ii. Non-nucleoside analogues agent</title>
<p>MG 98, a 20bp antisense oligodeoxynucleotide, specifically binds to 3′-UTR of DNMT1, and subsequently interfering DNMT1 expression. Many studies of MG98 have been carried out in various scopes while different results are obtained in different conditions. Rebecca B. Klisovic et al. reported that MG98 showed no effect in AML treatment [<xref ref-type="bibr" rid="R191">191</xref>]. Nonetheless, Robert J. Amato et al suggested that combination of MG98 and interferon-α-2β was capable of alleviating advanced renal cell carcinoma [<xref ref-type="bibr" rid="R192">192</xref>]. These differences may result from cancer-selectivity and combination with other agents of MG98. Thus, it is still fair fantastic to investigate antisense oligonucleotide focusing on its role in varied conditions and its combination with other agents.</p>
<p>RG108 is a newly synthesized inhibitor which functions by directly binding to active site of DNMT1. Bodo Brueckner et al. evidenced that RG108 could demethylate cancer cells significantly followed by TSGs re-expression. Notably, RG108 treatment did not manifest any toxicity [<xref ref-type="bibr" rid="R193">193</xref>]. Another study also showed that RG108 was capable of inhibiting proliferation of cancer cells. In addition, it demonstrated that its combination with histone acetylation inhibitors could strengthen potency of RG108 [<xref ref-type="bibr" rid="R194">194</xref>]. Interestingly, RG108 could meliorate stem cells therapy by improving anti-senescence of stem cells [<xref ref-type="bibr" rid="R195">195</xref>]. As a new DNMT inhibitor, RG108 deserves considerable exploration due to its low toxicity and other advantages.</p>
<p>In sum, nucleoside analogues are predominant demethylation agents targeting DNMT. Many of them have showed remarkable perspective and been applied as clinic regimens. Nevertheless, side effects emerge as another challenge for us. For example, decitabine interrupts RNA, DNA and protein synthesis both in sick and healthy cells, and thus being toxic. Therefore, biochemical synthesis is required to develop more effective and safer agents. That is why agents, such as MG98 and RG108, are synthesized.</p>
</sec>
</sec>
<sec id="s6_2">
<title>2. Demethylation agents targeting TET</title>
<p>As TETs are newly discovered methylation-associated enzymes, agents targeting them are on the way. However, several studies have given us insight into its bright future.</p>
<p>A study showed that vitamin C was able to induce TET-dependent demethylation in ES cells by activating TETs followed by genes re-expression. It suggested that agents targeting TET could alter stem cells destiny, and thus probably being applied in clinic [<xref ref-type="bibr" rid="R196">196</xref>]. In human cancer skin cells, vitamin C treatment conferred anti-apoptotic function to cells by activating TET, demethylating DNA, and thus re-patterning gene expression profile [<xref ref-type="bibr" rid="R197">197</xref>]. Additionally, vitamin C-mediated TET regulation was involved in nervous system development [<xref ref-type="bibr" rid="R150">150</xref>].</p>
<p>Although there is no specific agent targeting TETs due to their new membership in family of demethylation agents, what happens to DNMTs as well as great progress of TET studies inspires us to explore deeply and continuously.</p>
</sec>
</sec>
<sec id="s7">
<title>SUMMARY</title>
<p>Here, we summarized studies mainly pertaining to demethylation of 5hmC conversion mediated by TETs in several conditions as well as progress of TETs-associated therapeutics. We conclude that demethylation does play pivotal roles in cancer, embryogenesis, nervous system, CVS and other conditions despite poorly available studies in some categories, and these roles in these conditions are associated with proliferation, differentiation, DNA break repair, drug resistance and other process at transcription level. With these discoveries, 5hmC, similar with 5mC, is increasingly applied as a prognostic biomarker in disease advance and treatment. 5hmC reversing is capable of rectifying the disturbance resulting from methylation dysregulation in some diseases. To date, its effects in most cancers, embryogenesis and nervous system have been well established, but more studies about its role in other conditions like CVS are required. Moreover, researches of TETs-dependent demethylation agents are just at the beginning, more investigations are intensely required. Though there may be a long way, this way is fair fantastic and interesting.</p>
</sec>
</body>
<back>
<ack>
<p>This work was supported by the National Natural Science Fund of China (81573434), the Program for New Century Excellent Talents In Heilongjiang Provincial University (1252-NCET-013), and University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province (No. UNPYSCT- 2015034)</p>
</ack>
<fn-group>
<fn fn-type="COI-statement">
<p>
<bold>CONFLICTS OF INTERESTS</bold>
</p>
<p>The authors have declared that no competing interest exists.</p>
</fn>
</fn-group>
<ref-list>
<title>REFERENCES</title>
<ref id="R1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tuominen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jewell</surname>
<given-names>R</given-names>
</name>
<name>
<surname>van den Oord</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Wolter</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Stierner</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Lindholm</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hertzman Johansson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Linden</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Johansson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Frostvik Stolt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Snowden</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Newton-Bishop</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hansson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Egyhazi Brage</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma</article-title>
<source/>International journal of cancer
          <year>2015</year>
<volume>136</volume>
<fpage>2844</fpage>
<lpage>2853</lpage>
<pub-id pub-id-type="pmid">25400033</pub-id>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arribas</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Rinaldi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mensah</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Kwee</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Cascione</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Robles</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Martinez-Climent</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Oscier</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Arcaini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Baldini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Marasca</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Thieblemont</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Briere</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Forconi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zamo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bonifacio</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features</article-title>
<source/>Blood
          <year>2015</year>
<volume>125</volume>
<fpage>1922</fpage>
<lpage>1931</lpage>
<pub-id pub-id-type="pmid">25612624</pub-id>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castelo-Branco</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Choufani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mack</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gallagher</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lipman</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zhukova</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Merino</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wasserman</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Elizabeth</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Alon</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hovestadt</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Kool</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study</article-title>
<source/>The Lancet Oncology
          <year>2013</year>
<volume>14</volume>
<fpage>534</fpage>
<lpage>542</lpage>
<pub-id pub-id-type="pmid">23598174</pub-id>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goyal</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Reinhardt</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jeltsch</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Accuracy of DNA methylation pattern preservation by the Dnmt1 methyltransferase</article-title>
<source/>Nucleic acids research
          <year>2006</year>
<volume>34</volume>
<fpage>1182</fpage>
<lpage>1188</lpage>
<pub-id pub-id-type="pmid">16500889</pub-id>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Haber</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development</article-title>
<source/>Cell
          <year>1999</year>
<volume>99</volume>
<fpage>247</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="pmid">10555141</pub-id>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ehrlich</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gama-Sosa</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Midgett</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>McCune</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Gehrke</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells</article-title>
<source/>Nucleic Acids Res
          <year>1982</year>
<volume>10</volume>
<fpage>2709</fpage>
<lpage>2721</lpage>
<pub-id pub-id-type="pmid">7079182</pub-id>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>JU</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ming</surname>
<given-names>G-l</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain</article-title>
<source/>Cell
          <year>2011</year>
<volume>145</volume>
<fpage>423</fpage>
<lpage>434</lpage>
<pub-id pub-id-type="pmid">21496894</pub-id>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tahiliani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Pastor</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Bandukwala</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Brudno</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Agarwal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Iyer</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Aravind</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1</article-title>
<source/>Science (New York, N Y)
          <year>2009</year>
<volume>324</volume>
<fpage>930</fpage>
<lpage>935</lpage>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>YG</given-names>
</name>
</person-group>
<article-title>Tet family proteins and 5-hydroxymethylcytosine in development and disease</article-title>
<source/>Development (Cambridge, England)
          <year>2012</year>
<volume>139</volume>
<fpage>1895</fpage>
<lpage>1902</lpage>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ito</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Swenberg</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>He</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine</article-title>
<source/>Science
          <year>2011</year>
<volume>333</volume>
<fpage>1300</fpage>
<lpage>1303</lpage>
<pub-id pub-id-type="pmid">21778364</pub-id>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nagai</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ohno</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yuge</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hatano</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kinoshita</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype</article-title>
<source/>Blood
          <year>2002</year>
<volume>100</volume>
<fpage>2572</fpage>
<lpage>2577</lpage>
<pub-id pub-id-type="pmid">12239171</pub-id>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wutz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Smrzka</surname>
<given-names>OW</given-names>
</name>
<name>
<surname>Schweifer</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Schellander</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Barlow</surname>
<given-names>DP</given-names>
</name>
</person-group>
<article-title>Imprinted expression of the Igf2r gene depends on an intronic CpG island</article-title>
<source/>Nature
          <year>1997</year>
<volume>389</volume>
<fpage>745</fpage>
<lpage>749</lpage>
<pub-id pub-id-type="pmid">9338788</pub-id>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robertson</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Ait-Si-Ali</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yokochi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wade</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Wolffe</surname>
<given-names>AP</given-names>
</name>
</person-group>
<article-title>DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters</article-title>
<source/>Nature genetics
          <year>2000</year>
<volume>25</volume>
<fpage>338</fpage>
<lpage>342</lpage>
<pub-id pub-id-type="pmid">10888886</pub-id>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakamura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yonekawa</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kleihues</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ohgaki</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C —&gt; A:T mutations of the TP53 tumor suppressor gene</article-title>
<source/>Carcinogenesis
          <year>2001</year>
<volume>22</volume>
<fpage>1715</fpage>
<lpage>1719</lpage>
<pub-id pub-id-type="pmid">11577014</pub-id>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szulwach</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>C-X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Irier</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Upadhyay</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Gearing</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Levey</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Vasanthakumar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Godley</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>He</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging</article-title>
<source/>Nature neuroscience
          <year>2011</year>
<volume>14</volume>
<fpage>1607</fpage>
<lpage>1616</lpage>
<pub-id pub-id-type="pmid">22037496</pub-id>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Barbera</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nicholson</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells</article-title>
<source/>Molecular cell
          <year>2011</year>
<volume>42</volume>
<fpage>451</fpage>
<lpage>464</lpage>
<pub-id pub-id-type="pmid">21514197</pub-id>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ito</surname>
<given-names>S</given-names>
</name>
<name>
<surname>D'Alessio</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Taranova</surname>
<given-names>OV</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sowers</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification</article-title>
<source/>Nature
          <year>2010</year>
<volume>466</volume>
<fpage>1129</fpage>
<lpage>1133</lpage>
<pub-id pub-id-type="pmid">20639862</pub-id>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ko</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jankowska</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Pape</surname>
<given-names>UJ</given-names>
</name>
<name>
<surname>Tahiliani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bandukwala</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>An</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lamperti</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Ganetzky</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>XS</given-names>
</name>
<name>
<surname>Aravind</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Agarwal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Maciejewski</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2</article-title>
<source/>Nature
          <year>2010</year>
<volume>468</volume>
<fpage>839</fpage>
<lpage>843</lpage>
<pub-id pub-id-type="pmid">21057493</pub-id>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mellen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ayata</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dewell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kriaucionis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Heintz</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system</article-title>
<source/>Cell
          <year>2012</year>
<volume>151</volume>
<fpage>1417</fpage>
<lpage>1430</lpage>
<pub-id pub-id-type="pmid">23260135</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anand</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kunnumakkara</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Sundaram</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Harikumar</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Tharakan</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>OS</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Aggarwal</surname>
<given-names>BB</given-names>
</name>
</person-group>
<article-title>Cancer is a preventable disease that requires major lifestyle changes</article-title>
<source/>Pharm Res
          <year>2008</year>
<volume>25</volume>
<fpage>2097</fpage>
<lpage>2116</lpage>
<pub-id pub-id-type="pmid">18626751</pub-id>
</element-citation>
</ref>
<ref id="R21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Satake</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Ihara</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tsuge</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saida</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Betsui</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Okubo</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sakamoto</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ueno</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ikuno</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ishihara</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Iwahashi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ohishi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mano</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yamashita</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The First Nationwide Survey and Genetic Analyses of Bardet-Biedl Syndrome in Japan</article-title>
<source/>PLoS ONE
          <year>2015</year>
<volume>10</volume>
<fpage>e0136317</fpage>
<pub-id pub-id-type="pmid">26325687</pub-id>
</element-citation>
</ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meindl</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ditsch</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kast</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rhiem</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Schmutzler</surname>
<given-names>RK</given-names>
</name>
</person-group>
<article-title>Hereditary breast and ovarian cancer: new genes, new treatments, new concepts</article-title>
<source/>Dtsch Arztebl Int
          <year>2011</year>
<volume>108</volume>
<fpage>323</fpage>
<lpage>330</lpage>
<pub-id pub-id-type="pmid">21637635</pub-id>
</element-citation>
</ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waddington</surname>
<given-names>CH</given-names>
</name>
</person-group>
<article-title>The epigenotype. 1942</article-title>
<source/>Int J Epidemiol
          <year>2012</year>
<volume>41</volume>
<fpage>10</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="pmid">22186258</pub-id>
</element-citation>
</ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O'Leary</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cavicchioli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Haley</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Comino</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Merlano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mauri</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lackner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wischnewsky</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Crook</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lo Nigro</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Identification of Endoglin as an epigenetically regulated tumour-suppressor gene in lung cancer</article-title>
<source/>Br J Cancer
          <year>2015</year>
<volume>113</volume>
<fpage>970</fpage>
<lpage>978</lpage>
<pub-id pub-id-type="pmid">26325105</pub-id>
</element-citation>
</ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xue</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Mavis</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hernandez-Ilizaliturri</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Czuczman</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents</article-title>
<source/>J Cancer Res Clin Oncol
          <year>2016</year>
<volume>142</volume>
<fpage>379</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="pmid">26314218</pub-id>
</element-citation>
</ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Xi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation</article-title>
<source/>Oncotarget
          <year>2015</year>
<volume>6</volume>
<fpage>25533</fpage>
<lpage>25574</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.4575</pub-id>
<pub-id pub-id-type="pmid">26325180</pub-id>
</element-citation>
</ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ehrlich</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>DNA methylation in cancer: too much, but also too little</article-title>
<source/>Oncogene
          <year>2002</year>
<volume>21</volume>
<fpage>5400</fpage>
<lpage>5413</lpage>
<pub-id pub-id-type="pmid">12154403</pub-id>
</element-citation>
</ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Townsend</surname>
<given-names>CM</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Evers</surname>
<given-names>BM</given-names>
</name>
</person-group>
<article-title>Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells</article-title>
<source/>Oncotarget
          <year>2015</year>
<volume>6</volume>
<fpage>26960</fpage>
<lpage>26970</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.4745</pub-id>
<pub-id pub-id-type="pmid">26298774</pub-id>
</element-citation>
</ref>
<ref id="R29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lando</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fjeldbo</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Wilting</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>B</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Aarnes</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Forsberg</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Kristensen</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Steenbergen</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Lyng</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer</article-title>
<source/>Epigenetics
          <year>2015</year>
<volume>10</volume>
<fpage>970</fpage>
<lpage>980</lpage>
<pub-id pub-id-type="pmid">26291246</pub-id>
</element-citation>
</ref>
<ref id="R30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdelmaksoud-Dammak</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Saadallah-Kallel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Miladi-Abdennadher</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ayedi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Khabir</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sallemi-Boudawara</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Frikha</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Daoud</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mokdad-Gargouri</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) and P53 mutation pattern in sporadic colorectal cancer</article-title>
<source/>Tumour Biol
          <year>2016</year>
<volume>37</volume>
<fpage>1707</fpage>
<lpage>1714</lpage>
<pub-id pub-id-type="pmid">26314856</pub-id>
</element-citation>
</ref>
<ref id="R31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Sheen</surname>
<given-names>IS</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Shyu</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Liaw</surname>
<given-names>YF</given-names>
</name>
</person-group>
<article-title>Genome-wide hypomethylation in hepatocellular carcinogenesis</article-title>
<source/>Cancer research
          <year>2001</year>
<volume>61</volume>
<fpage>4238</fpage>
<lpage>4243</lpage>
<pub-id pub-id-type="pmid">11358850</pub-id>
</element-citation>
</ref>
<ref id="R32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ehrlich</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Fiala</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dome</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>TI</given-names>
</name>
<name>
<surname>Youn</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sohn</surname>
<given-names>O-S</given-names>
</name>
<name>
<surname>Widschwendter</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tomlinson</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Chintagumpala</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Champagne</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Parham</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Malik</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Laird</surname>
<given-names>PW</given-names>
</name>
</person-group>
<article-title>Hypomethylation and hypermethylation of DNA in Wilms tumors</article-title>
<source/>Oncogene
          <year>2002</year>
<volume>21</volume>
<fpage>6694</fpage>
<lpage>6702</lpage>
<pub-id pub-id-type="pmid">12242669</pub-id>
</element-citation>
</ref>
<ref id="R33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Penn</surname>
<given-names>NW</given-names>
</name>
<name>
<surname>Suwalski</surname>
<given-names>R</given-names>
</name>
<name>
<surname>O'Riley</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bojanowski</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yura</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid</article-title>
<source/>The Biochemical journal
          <year>1972</year>
<volume>126</volume>
<fpage>781</fpage>
<lpage>790</lpage>
<pub-id pub-id-type="pmid">4538516</pub-id>
</element-citation>
</ref>
<ref id="R34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lian</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ceol</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Larson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dresser</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lian</surname>
<given-names>BQ</given-names>
</name>
<name>
<surname>Kleffel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Neiswender</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma</article-title>
<source/>Cell
          <year>2012</year>
<volume>150</volume>
<fpage>1135</fpage>
<lpage>1146</lpage>
<pub-id pub-id-type="pmid">22980977</pub-id>
</element-citation>
</ref>
<ref id="R35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kudo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tateishi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Asaoka</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ijichi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nagae</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Aburatani</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Koike</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation</article-title>
<source/>Cancer Sci
          <year>2012</year>
<volume>103</volume>
<fpage>670</fpage>
<lpage>676</lpage>
<pub-id pub-id-type="pmid">22320381</pub-id>
</element-citation>
</ref>
<ref id="R36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>W</given-names>
</name>
<name>
<surname>He</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients</article-title>
<source/>Journal of biomedical nanotechnology
          <year>2013</year>
<volume>9</volume>
<fpage>1607</fpage>
<lpage>1616</lpage>
<pub-id pub-id-type="pmid">23980508</pub-id>
</element-citation>
</ref>
<ref id="R37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>ZD</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>ZQ</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation</article-title>
<source/>Oncogene
          <year>2013</year>
<volume>32</volume>
<fpage>663</fpage>
<lpage>669</lpage>
<pub-id pub-id-type="pmid">22391558</pub-id>
</element-citation>
</ref>
<ref id="R38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cimmino</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dawlaty</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Ndiaye-Lobry</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yap</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Bakogianni</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bhattacharyya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shaknovich</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Geng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lobry</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mullenders</surname>
<given-names>J</given-names>
</name>
<name>
<surname>King</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Trimarchi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Aranda-Orgilles</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>TET1 is a tumor suppressor of hematopoietic malignancy</article-title>
<source/>Nature immunology
          <year>2015</year>
<volume>16</volume>
<fpage>653</fpage>
<lpage>662</lpage>
<pub-id pub-id-type="pmid">25867473</pub-id>
</element-citation>
</ref>
<ref id="R39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsai</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Davalath</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rankin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Radich</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Head</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Appelbaum</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Boldt</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies</article-title>
<source/>Leukemia
          <year>1996</year>
<volume>10</volume>
<fpage>1901</fpage>
<lpage>1910</lpage>
<pub-id pub-id-type="pmid">8946929</pub-id>
</element-citation>
</ref>
<ref id="R40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tawana</surname>
<given-names>Kiran</given-names>
<suffix>MBChB, FRCPath</suffix>
</name>
<name>
<surname>Fitzgibbon</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>CEBPA-Associated Familial Acute Myeloid Leukemia (AML) BTI - GeneReviews(R)</article-title>
<source/>GeneReviews
          <year>1993</year>
</element-citation>
</ref>
<ref id="R41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines</article-title>
<source/>Mol Cell Biol
          <year>1990</year>
<volume>10</volume>
<fpage>5502</fpage>
<lpage>5509</lpage>
<pub-id pub-id-type="pmid">2144611</pub-id>
</element-citation>
</ref>
<ref id="R42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daley</surname>
<given-names>GQ</given-names>
</name>
<name>
<surname>Van Etten</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Baltimore</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome</article-title>
<source/>Science
          <year>1990</year>
<volume>247</volume>
<fpage>824</fpage>
<lpage>830</lpage>
<pub-id pub-id-type="pmid">2406902</pub-id>
</element-citation>
</ref>
<ref id="R43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gauwerky</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Croce</surname>
<given-names>CM</given-names>
</name>
</person-group>
<article-title>Chromosomal translocations in leukaemia</article-title>
<source/>Semin Cancer Biol
          <year>1993</year>
<volume>4</volume>
<fpage>333</fpage>
<lpage>340</lpage>
<pub-id pub-id-type="pmid">8142618</pub-id>
</element-citation>
</ref>
<ref id="R44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Viguie</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Aboura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bouscary</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ramond</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Delmer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tachdjian</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Marie</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Casadevall</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Common 4q24 deletion in four cases of hematopoietic malignancy: early stem cell involvement?</article-title>
<source/>Leukemia
          <year>2005</year>
<volume>19</volume>
<fpage>1411</fpage>
<lpage>1415</lpage>
<pub-id pub-id-type="pmid">15920487</pub-id>
</element-citation>
</ref>
<ref id="R45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Figueroa</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Abdel-Wahab</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shih</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bhagwat</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Vasanthakumar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>HF</given-names>
</name>
<name>
<surname>Tallman</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wolniak</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Peeters</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Choe</surname>
<given-names>SE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation</article-title>
<source/>Cancer Cell
          <year>2010</year>
<volume>18</volume>
<fpage>553</fpage>
<lpage>567</lpage>
<pub-id pub-id-type="pmid">21130701</pub-id>
</element-citation>
</ref>
<ref id="R46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kroeze</surname>
<given-names>LI</given-names>
</name>
<name>
<surname>Aslanyan</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>van Rooij</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Koorenhof-Scheele</surname>
<given-names>TN</given-names>
</name>
<name>
<surname>Massop</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Carell</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Boezeman</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Marie</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Halkes</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>de Witte</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Huls</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Suciu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wevers</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>van der Reijden</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Characterization of acute myeloid leukemia based on levels of global hydroxymethylation</article-title>
<source/>Blood
          <year>2014</year>
<volume>124</volume>
<fpage>1110</fpage>
<lpage>1118</lpage>
<pub-id pub-id-type="pmid">24986689</pub-id>
</element-citation>
</ref>
<ref id="R47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogawara</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Katsumoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Aikawa</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shima</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kagiyama</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Soga</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Matsunaga</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Seki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Araki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kitabayashi</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia</article-title>
<source/>Cancer research
          <year>2015</year>
<volume>75</volume>
<fpage>2005</fpage>
<lpage>2016</lpage>
<pub-id pub-id-type="pmid">25795706</pub-id>
</element-citation>
</ref>
<ref id="R48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chotirat</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Thongnoppakhun</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wanachiwanawin</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Auewarakul</surname>
<given-names>CU</given-names>
</name>
</person-group>
<article-title>Acquired somatic mutations of isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) in preleukemic disorders</article-title>
<source/>Blood cells, molecules &amp; diseases
          <year>2015</year>
<volume>54</volume>
<fpage>286</fpage>
<lpage>291</lpage>
</element-citation>
</ref>
<ref id="R49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sardina</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Graf</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>A new path to leukemia with WIT</article-title>
<source/>Molecular cell
          <year>2015</year>
<volume>57</volume>
<fpage>573</fpage>
<lpage>574</lpage>
<pub-id pub-id-type="pmid">25699704</pub-id>
</element-citation>
</ref>
<ref id="R50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rampal</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Alkalin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Madzo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vasanthakumar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pronier</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Abdel-Wahab</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Shih</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Hricik</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tosello</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Tallman</surname>
<given-names>JE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia</article-title>
<source/>Cell reports
          <year>2014</year>
<volume>9</volume>
<fpage>1841</fpage>
<lpage>1855</lpage>
<pub-id pub-id-type="pmid">25482556</pub-id>
</element-citation>
</ref>
<ref id="R51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jiao</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>K-L</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation</article-title>
<source/>Molecular cell
          <year>2015</year>
<volume>57</volume>
<fpage>662</fpage>
<lpage>673</lpage>
<pub-id pub-id-type="pmid">25601757</pub-id>
</element-citation>
</ref>
<ref id="R52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCarty</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Loeb</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>Hypoxia-sensitive epigenetic regulation of an antisense-oriented lncRNA controls WT1 expression in myeloid leukemia cells</article-title>
<source/>PLoS ONE
          <year>2015</year>
<volume>10</volume>
<fpage>e0119837</fpage>
<pub-id pub-id-type="pmid">25794157</pub-id>
</element-citation>
</ref>
<ref id="R53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakagawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>D'Alessio</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Nakayama</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>H-Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>CRL4(VprBP) E3 ligase promotes monoubiquitylation and chromatin binding of TET dioxygenases</article-title>
<source/>Molecular cell
          <year>2015</year>
<volume>57</volume>
<fpage>247</fpage>
<lpage>260</lpage>
<pub-id pub-id-type="pmid">25557551</pub-id>
</element-citation>
</ref>
<ref id="R54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rasmussen</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Helin</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>TET1: an epigenetic guardian of lymphomagenesis</article-title>
<source/>Nature immunology
          <year>2015</year>
<volume>16</volume>
<fpage>592</fpage>
<lpage>594</lpage>
<pub-id pub-id-type="pmid">25988898</pub-id>
</element-citation>
</ref>
<ref id="R55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cimmino</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dawlaty</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Ndiaye-Lobry</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yap</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Bakogianni</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bhattacharyya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shaknovich</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Geng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lobry</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mullenders</surname>
<given-names>J</given-names>
</name>
<name>
<surname>King</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Trimarchi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Aranda-Orgilles</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Erratum: TET1 is a tumor suppressor of hematopoietic malignancy</article-title>
<source/>Nature immunology
          <year>2015</year>
<volume>16</volume>
<fpage>889</fpage>
</element-citation>
</ref>
<ref id="R56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quivoron</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Couronne</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Della Valle</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Plo</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Wagner-Ballon</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Do Cruzeiro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Delhommeau</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Arnulf</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Stern</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Godley</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Opolon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tilly</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Solary</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Duffourd</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Dessen</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis</article-title>
<source/>Cancer Cell
          <year>2011</year>
<volume>20</volume>
<fpage>25</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="pmid">21723201</pub-id>
</element-citation>
</ref>
<ref id="R57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asmar</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Punj</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Christensen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Hother</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ralfkiaer</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ralfkiaer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Helin</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gronbak</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma</article-title>
<source/>Haematologica
          <year>2013</year>
<volume>98</volume>
<fpage>1912</fpage>
<lpage>1920</lpage>
<pub-id pub-id-type="pmid">23831920</pub-id>
</element-citation>
</ref>
<ref id="R58">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cimmino</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dawlaty</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Ndiaye-Lobry</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yap</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Bakogianni</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bhattacharyya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shaknovich</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Geng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lobry</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mullenders</surname>
<given-names>J</given-names>
</name>
<name>
<surname>King</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Trimarchi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Aranda-Orgilles</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>TET1 is a tumor suppressor of hematopoietic malignancy</article-title>
<source/>Nat Immunol
          <year>2015</year>
<volume>16</volume>
<fpage>653</fpage>
<lpage>662</lpage>
<pub-id pub-id-type="pmid">25867473</pub-id>
</element-citation>
</ref>
<ref id="R59">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lemonnier</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Couronne</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Parrens</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jais</surname>
<given-names>J-P</given-names>
</name>
<name>
<surname>Travert</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lamant</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tournillac</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Rousset</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Fabiani</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cairns</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Mak</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bastard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bernard</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>de Leval</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gaulard</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters</article-title>
<source/>Blood
          <year>2012</year>
<volume>120</volume>
<fpage>1466</fpage>
<lpage>1469</lpage>
<pub-id pub-id-type="pmid">22760778</pub-id>
</element-citation>
</ref>
<ref id="R60">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quivoron</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Couronne</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Della Valle</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Plo</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Wagner-Ballon</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Do Cruzeiro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Delhommeau</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Arnulf</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Stern</surname>
<given-names>M-H</given-names>
</name>
<name>
<surname>Godley</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Opolon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tilly</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Solary</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Duffourd</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Dessen</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis</article-title>
<source/>Cancer cell
          <year>2011</year>
<volume>20</volume>
<fpage>25</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="pmid">21723201</pub-id>
</element-citation>
</ref>
<ref id="R61">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Couronne</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bastard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bernard</surname>
<given-names>OA</given-names>
</name>
</person-group>
<article-title>TET2 and DNMT3A mutations in human T-cell lymphoma</article-title>
<source/>The New England journal of medicine
          <year>2012</year>
<volume>366</volume>
<fpage>95</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="pmid">22216861</pub-id>
</element-citation>
</ref>
<ref id="R62">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Odejide</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Weigert</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Toscano</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lunning</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Kopp</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>van Bodegom</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bolla</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schatz</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Teruya-Feldstein</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hochberg</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Louissaint</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dorfman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Stevenson</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rodig</surname>
<given-names>SJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A targeted mutational landscape of angioimmunoblastic T-cell lymphoma</article-title>
<source/>Blood
          <year>2014</year>
<volume>123</volume>
<fpage>1293</fpage>
<lpage>1296</lpage>
<pub-id pub-id-type="pmid">24345752</pub-id>
</element-citation>
</ref>
<ref id="R63">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakata-Yanagimoto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Enami</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shiraishi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ishii</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Miyake</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Muto</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tsuyama</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sato-Otsubo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Okuno</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sakata</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kamada</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nakamoto-Matsubara</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>NB</given-names>
</name>
<name>
<surname>Izutsu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Somatic RHOA mutation in angioimmunoblastic T cell lymphoma</article-title>
<source/>Nature genetics
          <year>2014</year>
<volume>46</volume>
<fpage>171</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="pmid">24413737</pub-id>
</element-citation>
</ref>
<ref id="R64">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galm</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Wilop</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Reichelt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jost</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gehbauer</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Herman</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Osieka</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>DNA methylation changes in multiple myeloma</article-title>
<source/>Leukemia
          <year>2004</year>
<volume>18</volume>
<fpage>1687</fpage>
<lpage>1692</lpage>
<pub-id pub-id-type="pmid">15318245</pub-id>
</element-citation>
</ref>
<ref id="R65">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galm</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Yoshikawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Esteller</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Osieka</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Herman</surname>
<given-names>JG</given-names>
</name>
</person-group>
<article-title>SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma</article-title>
<source/>Blood
          <year>2003</year>
<volume>101</volume>
<fpage>2784</fpage>
<lpage>2788</lpage>
<pub-id pub-id-type="pmid">12456503</pub-id>
</element-citation>
</ref>
<ref id="R66">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Troppan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hofer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wenzl</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lassnig</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pursche</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Steinbauer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Wiltgen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zulus</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Renner</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Beham-Schmid</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Deutsch</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Neumeister</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Frequent down regulation of the tumor suppressor gene a20 in multiple myeloma</article-title>
<source/>PLoS ONE
          <year>2015</year>
<volume>10</volume>
<fpage>e0123922</fpage>
<pub-id pub-id-type="pmid">25856582</pub-id>
</element-citation>
</ref>
<ref id="R67">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>LQ</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>KY</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>ZY</given-names>
</name>
<name>
<surname>Chim</surname>
<given-names>CS</given-names>
</name>
</person-group>
<article-title>Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma</article-title>
<source/>Journal of clinical pathology
          <year>2015</year>
<volume>68</volume>
<fpage>557</fpage>
<lpage>561</lpage>
<pub-id pub-id-type="pmid">25855800</pub-id>
</element-citation>
</ref>
<ref id="R68">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heuck</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bhagat</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gundabolu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chrysofakis</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Schinke</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tariman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vickrey</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pulliam</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nischal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bhattacharyya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Meagher</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis</article-title>
<source/>Journal of immunology
          <year>2013</year>
<volume>190</volume>
<fpage>2966</fpage>
<lpage>2975</lpage>
</element-citation>
</ref>
<ref id="R69">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agirre</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Castellano</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pascual</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Heath</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kulis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Segura</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bergmann</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Esteve</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Merkel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Raineri</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Agueda</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Blanc</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Datta</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Russinol</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers</article-title>
<source/>Genome research
          <year>2015</year>
<volume>25</volume>
<fpage>478</fpage>
<lpage>487</lpage>
<pub-id pub-id-type="pmid">25644835</pub-id>
</element-citation>
</ref>
<ref id="R70">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyamoto</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Oda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nakao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Baba</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma</article-title>
<source/>Oncotarget
          <year>2015</year>
<volume>6</volume>
<fpage>23372</fpage>
<lpage>23382</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.4281</pub-id>
<pub-id pub-id-type="pmid">26093090</pub-id>
</element-citation>
</ref>
<ref id="R71">
<label>71</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kudo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tateishi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Asaoka</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ijichi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nagae</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Aburatani</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Koike</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation</article-title>
<source/>Cancer science
          <year>2012</year>
<volume>103</volume>
<fpage>670</fpage>
<lpage>676</lpage>
<pub-id pub-id-type="pmid">22320381</pub-id>
</element-citation>
</ref>
<ref id="R72">
<label>72</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frycz</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Murawa</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Borejsza-Wysocki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Marciniak</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Murawa</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Drews</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kolodziejczak</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tomela</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Jagodzinski</surname>
<given-names>PP</given-names>
</name>
</person-group>
<article-title>Decreased expression of ten-eleven translocation 1 protein is associated with some clinicopathological features in gastric cancer</article-title>
<source/>Biomedicine &amp; Pharmacotherapy
          <year>2014</year>
<volume>68</volume>
<fpage>209</fpage>
<lpage>212</lpage>
<pub-id pub-id-type="pmid">24507562</pub-id>
</element-citation>
</ref>
<ref id="R73">
<label>73</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kurabe</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Matsushima</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kahyo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ohnishi</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Tanioka</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Tajima</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Goto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shinmura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Konno</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sugimura</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer</article-title>
<source/>Gastric cancer
          <year>2015</year>
<volume>18</volume>
<fpage>516</fpage>
<lpage>525</lpage>
<pub-id pub-id-type="pmid">25098926</pub-id>
</element-citation>
</ref>
<ref id="R74">
<label>74</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>J-L</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>O-H</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S-Y</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>YS</given-names>
</name>
</person-group>
<article-title>Abstract 394: TET1, which act as an tumor suppressor gene, is suppressed by DNA hypermethylation in gastric cancer</article-title>
<source/>Cancer Research
          <year>2014</year>
<volume>74</volume>
<fpage>394</fpage>
</element-citation>
</ref>
<ref id="R75">
<label>75</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>DX</given-names>
</name>
</person-group>
<article-title>TET1 exerts its tumor suppressor function by interacting with p53-EZH2 pathway in gastric cancer</article-title>
<source/>J Biomed Nanotechnol
          <year>2014</year>
<volume>10</volume>
<fpage>1217</fpage>
<lpage>1230</lpage>
<pub-id pub-id-type="pmid">24804542</pub-id>
</element-citation>
</ref>
<ref id="R76">
<label>76</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Distribution of 5-hydroxymethylcytosine in different human tissues</article-title>
<source/>Journal of nucleic acids
          <year>2011</year>
<volume>2011</volume>
<fpage>870726</fpage>
<pub-id pub-id-type="pmid">21772996</pub-id>
</element-citation>
</ref>
<ref id="R77">
<label>77</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hur</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cejas</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Feliu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Moreno-Rubio</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Burgos</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Boland</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Goel</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis</article-title>
<source/>Gut
          <year>2014</year>
<volume>63</volume>
<fpage>635</fpage>
<lpage>646</lpage>
<pub-id pub-id-type="pmid">23704319</pub-id>
</element-citation>
</ref>
<ref id="R78">
<label>78</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ichimura</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Shinjo</surname>
<given-names>K</given-names>
</name>
<name>
<surname>An</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yamao</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ohka</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Katsushima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hatanaka</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tojo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ueda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer</article-title>
<source/>Cancer prevention research (Philadelphia, Pa)
          <year>2015</year>
<volume>8</volume>
<fpage>702</fpage>
<lpage>711</lpage>
</element-citation>
</ref>
<ref id="R79">
<label>79</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neri</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dettori</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Incarnato</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Krepelova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rapelli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Maldotti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Parlato</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Paliogiannis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Oliviero</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway</article-title>
<source/>Oncogene
          <year>2015</year>
<volume>34</volume>
<fpage>4168</fpage>
<lpage>4176</lpage>
<pub-id pub-id-type="pmid">25362856</pub-id>
</element-citation>
</ref>
<ref id="R80">
<label>80</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uribe-Lewis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Stark</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Dunning</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Bachman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Stojic</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Halim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vowler</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Delatte</surname>
<given-names>B</given-names>
</name>
<name>
<surname>de Bony</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Colin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Defrance</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Krueger</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>A-L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer</article-title>
<source/>Genome biology
          <year>2015</year>
<volume>16</volume>
<fpage>69</fpage>
<pub-id pub-id-type="pmid">25853800</pub-id>
</element-citation>
</ref>
<ref id="R81">
<label>81</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>XQ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>YF</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>YF</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>ZM</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>YQ</given-names>
</name>
</person-group>
<article-title>Promoter demethylation of nuclear factor-erythroid 2-related factor 2 gene in drug-resistant colon cancer cells</article-title>
<source/>Oncology Letters
          <year>2015</year>
<volume>10</volume>
<fpage>1287</fpage>
<lpage>1292</lpage>
<pub-id pub-id-type="pmid">26622665</pub-id>
</element-citation>
</ref>
<ref id="R82">
<label>82</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Piao</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>WY</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>IC</given-names>
</name>
<name>
<surname>Keum</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Surh</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Hyun</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation</article-title>
<source/>Cell death &amp; disease
          <year>2014</year>
<volume>5</volume>
<fpage>e1183</fpage>
<pub-id pub-id-type="pmid">24743738</pub-id>
</element-citation>
</ref>
<ref id="R83">
<label>83</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kraus</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Globisch</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Eigenbrod</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Widmann</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Munzel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pfaffeneder</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hackner</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Feiden</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Schuller</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Carell</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kretzschmar</surname>
<given-names>HA</given-names>
</name>
</person-group>
<article-title>Low values of 5-hydroxymethylcytosine (5hmC), the “sixth base,” are associated with anaplasia in human brain tumors</article-title>
<source/>Int J Cancer
          <year>2012</year>
<volume>131</volume>
<fpage>1577</fpage>
<lpage>1590</lpage>
<pub-id pub-id-type="pmid">22234893</pub-id>
</element-citation>
</ref>
<ref id="R84">
<label>84</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rauch</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Schackert</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Krex</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Pfeifer</surname>
<given-names>GP</given-names>
</name>
</person-group>
<article-title>5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations</article-title>
<source/>Cancer Res
          <year>2011</year>
<volume>71</volume>
<fpage>7360</fpage>
<lpage>7365</lpage>
<pub-id pub-id-type="pmid">22052461</pub-id>
</element-citation>
</ref>
<ref id="R85">
<label>85</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orr</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Haffner</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Yegnasubramanian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Eberhart</surname>
<given-names>CG</given-names>
</name>
</person-group>
<article-title>Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<fpage>e41036</fpage>
<pub-id pub-id-type="pmid">22829908</pub-id>
</element-citation>
</ref>
<ref id="R86">
<label>86</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turcan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rohle</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Goenka</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yilmaz</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Campos</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fabius</surname>
<given-names>AWM</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Guryanova</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Heguy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Viale</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype</article-title>
<source/>Nature
          <year>2012</year>
<volume>483</volume>
<fpage>479</fpage>
<lpage>U137</lpage>
<pub-id pub-id-type="pmid">22343889</pub-id>
</element-citation>
</ref>
<ref id="R87">
<label>87</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muller</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gessi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Waha</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Isselstein</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Luxen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Freihoff</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Freihoff</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hammes</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Denkhaus</surname>
<given-names>D</given-names>
</name>
<name>
<surname>zur Muhlen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pietsch</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Waha</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Nuclear Exclusion of TET1 Is Associated with Loss of 5-Hydroxymethylcytosine in IDH1 Wild-Type Gliomas</article-title>
<source/>American Journal of Pathology
          <year>2012</year>
<volume>181</volume>
<fpage>675</fpage>
<lpage>683</lpage>
<pub-id pub-id-type="pmid">22688054</pub-id>
</element-citation>
</ref>
<ref id="R88">
<label>88</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orr</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Haffner</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Yegnasubramanian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Eberhart</surname>
<given-names>CG</given-names>
</name>
</person-group>
<article-title>Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma</article-title>
<source/>PLoS ONE
          <year>2012</year>
<volume>7</volume>
<fpage>e41036</fpage>
<pub-id pub-id-type="pmid">22829908</pub-id>
</element-citation>
</ref>
<ref id="R89">
<label>89</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kraus</surname>
<given-names>Theo F. J.</given-names>
</name>
<name>
<surname>Kolck</surname>
<given-names>Gesa</given-names>
</name>
<name>
<surname>Greiner</surname>
<given-names>Andrea</given-names>
</name>
<name>
<surname>Schierl</surname>
<given-names>Katharina</given-names>
</name>
<name>
<surname>Guibourt</surname>
<given-names>Virginie</given-names>
</name>
<name>
<surname>Kretzschmar</surname>
<given-names>Hans A.</given-names>
</name>
</person-group>
<article-title>Loss of 5-hydroxymethylcytosine and intratumoral heterogeneity as an epigenomic hallmark of glioblastoma</article-title>
<source/>Tumor Biol
          <year>2015</year>
<volume>36</volume>
<fpage>8439</fpage>
<lpage>8446</lpage>
</element-citation>
</ref>
<ref id="R90">
<label>90</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kraus</surname>
<given-names>TFJ</given-names>
</name>
<name>
<surname>Greiner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Steinmaurer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dietinger</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Guibourt</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Kretzschmar</surname>
<given-names>HA</given-names>
</name>
</person-group>
<article-title>Genetic Characterization of Ten-Eleven-Translocation Methylcytosine Dioxygenase Alterations in Human Glioma</article-title>
<source/>Journal of Cancer
          <year>2015</year>
<volume>6</volume>
<fpage>832</fpage>
<lpage>842</lpage>
<pub-id pub-id-type="pmid">26284134</pub-id>
</element-citation>
</ref>
<ref id="R91">
<label>91</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gambichler</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sand</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Skrygan</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma</article-title>
<source/>Melanoma research
          <year>2013</year>
<volume>23</volume>
<fpage>218</fpage>
<lpage>220</lpage>
<pub-id pub-id-type="pmid">23458759</pub-id>
</element-citation>
</ref>
<ref id="R92">
<label>92</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hon</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Hawkins</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Caballero</surname>
<given-names>OL</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lister</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pelizzola</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Valsesia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Kuan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Edsall</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Camargo</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Stevenson</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Ecker</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Bafna</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Strausberg</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>AJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer</article-title>
<source/>Genome research
          <year>2012</year>
<volume>22</volume>
<fpage>246</fpage>
<lpage>258</lpage>
<pub-id pub-id-type="pmid">22156296</pub-id>
</element-citation>
</ref>
<ref id="R93">
<label>93</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jawert</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hasseus</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kjeller</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Magnusson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sand</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Larsson</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Loss of 5-hydroxymethylcytosine and TET2 in oral squamous cell carcinoma</article-title>
<source/>Anticancer research
          <year>2013</year>
<volume>33</volume>
<fpage>4325</fpage>
<lpage>4328</lpage>
<pub-id pub-id-type="pmid">24122999</pub-id>
</element-citation>
</ref>
<ref id="R94">
<label>94</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer</article-title>
<source/>Gene
          <year>2014</year>
<volume>543</volume>
<fpage>101</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="pmid">24704024</pub-id>
</element-citation>
</ref>
<ref id="R95">
<label>95</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santos</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hendrich</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Reik</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Dynamic reprogramming of DNA methylation in the early mouse embryo</article-title>
<source/>Developmental Biology
          <year>2002</year>
<volume>241</volume>
<fpage>172</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="pmid">11784103</pub-id>
</element-citation>
</ref>
<ref id="R96">
<label>96</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frank</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Keshet</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Shani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Razin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cedar</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Demethylation of Cpg Islands in Embryonic-Cells</article-title>
<source/>Nature
          <year>1991</year>
<volume>351</volume>
<fpage>239</fpage>
<lpage>241</lpage>
<pub-id pub-id-type="pmid">2041571</pub-id>
</element-citation>
</ref>
<ref id="R97">
<label>97</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayer</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Niveleau</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fundele</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Haaf</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Embryogenesis - Demethylation of the zygotic paternal genome</article-title>
<source/>Nature
          <year>2000</year>
<volume>403</volume>
<fpage>501</fpage>
<lpage>502</lpage>
<pub-id pub-id-type="pmid">10676950</pub-id>
</element-citation>
</ref>
<ref id="R98">
<label>98</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>ZD</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Mikkelsen</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Gnirke</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Regev</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Meissner</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>A unique regulatory phase of DNA methylation in the early mammalian embryo</article-title>
<source/>Nature
          <year>2012</year>
<volume>484</volume>
<fpage>339</fpage>
<lpage>U374</lpage>
<pub-id pub-id-type="pmid">22456710</pub-id>
</element-citation>
</ref>
<ref id="R99">
<label>99</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaudet</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Rideout</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Meissner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dausman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Leonhardt</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jaenisch</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Dnmt1 expression in pre- and postimplantation embryogenesis and the maintenance of IAP silencing</article-title>
<source/>Molecular and Cellular Biology
          <year>2004</year>
<volume>24</volume>
<fpage>1640</fpage>
<lpage>1648</lpage>
<pub-id pub-id-type="pmid">14749379</pub-id>
</element-citation>
</ref>
<ref id="R100">
<label>100</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biniszkiewicz</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gribnau</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ramsahoye</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gaudet</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Eggan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Humpherys</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mastrangelo</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Jun</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jaenisch</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality</article-title>
<source/>Molecular and Cellular Biology
          <year>2002</year>
<volume>22</volume>
<fpage>2124</fpage>
<lpage>2135</lpage>
<pub-id pub-id-type="pmid">11884600</pub-id>
</element-citation>
</ref>
<ref id="R101">
<label>101</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howell</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Bestor</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Latham</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Mertineit</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Trasler</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Chaillet</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Genomic imprinting disrupted by a maternal effect mutation in the Dnmt1 gene</article-title>
<source/>Cell
          <year>2001</year>
<volume>104</volume>
<fpage>829</fpage>
<lpage>838</lpage>
<pub-id pub-id-type="pmid">11290321</pub-id>
</element-citation>
</ref>
<ref id="R102">
<label>102</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hackett</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Sengupta</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zylicz</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Murakami</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Down</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Surani</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Germline DNA Demethylation Dynamics and Imprint Erasure Through 5-Hydroxymethylcytosine</article-title>
<source/>Science
          <year>2013</year>
<volume>339</volume>
<fpage>448</fpage>
<lpage>452</lpage>
<pub-id pub-id-type="pmid">23223451</pub-id>
</element-citation>
</ref>
<ref id="R103">
<label>103</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lienharda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pastor</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Chawla</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Novotny</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tsagaratou</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lasken</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Surani</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Koralov</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Kalantry</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chavez</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Simultaneous deletion of the methylcytosine oxidases Tet1 and Tet3 increases transcriptome variability in early embryogenesis</article-title>
<source/>Proceedings of the National Academy of Sciences of the United States of America
          <year>2015</year>
<volume>112</volume>
<fpage>E4236</fpage>
<lpage>E4245</lpage>
<pub-id pub-id-type="pmid">26199412</pub-id>
</element-citation>
</ref>
<ref id="R104">
<label>104</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>ZB</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Dynamic reprogramming of 5-hydroxymethylcytosine during early porcine embryogenesis</article-title>
<source/>Theriogenology
          <year>2014</year>
<volume>81</volume>
<fpage>496</fpage>
<lpage>508</lpage>
<pub-id pub-id-type="pmid">24315686</pub-id>
</element-citation>
</ref>
<ref id="R105">
<label>105</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fritz</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Papavasiliou</surname>
<given-names>FN</given-names>
</name>
</person-group>
<article-title>Cytidine deaminases: AIDing DNA demethylation?</article-title>
<source/>Genes Dev
          <year>2010</year>
<volume>24</volume>
<fpage>2107</fpage>
<lpage>2114</lpage>
<pub-id pub-id-type="pmid">20889711</pub-id>
</element-citation>
</ref>
<ref id="R106">
<label>106</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>XJ</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>JK</given-names>
</name>
</person-group>
<article-title>Regulation and function of DNA methylation in plants and animals</article-title>
<source/>Cell Res
          <year>2011</year>
<volume>21</volume>
<fpage>442</fpage>
<lpage>465</lpage>
<pub-id pub-id-type="pmid">21321601</pub-id>
</element-citation>
</ref>
<ref id="R107">
<label>107</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inoue</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Replication-dependent loss of 5-hydroxymethylcytosine in mouse preimplantation embryos</article-title>
<source/>Science
          <year>2011</year>
<volume>334</volume>
<fpage>194</fpage>
<pub-id pub-id-type="pmid">21940858</pub-id>
</element-citation>
</ref>
<ref id="R108">
<label>108</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kohli</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>TET enzymes, TDG and the dynamics of DNA demethylation</article-title>
<source/>Nature
          <year>2013</year>
<volume>502</volume>
<fpage>472</fpage>
<lpage>479</lpage>
<pub-id pub-id-type="pmid">24153300</pub-id>
</element-citation>
</ref>
<ref id="R109">
<label>109</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inoue</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>He</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Generation and replication-dependent dilution of 5fC and 5caC during mouse preimplantation development</article-title>
<source/>Cell Res
          <year>2011</year>
<volume>21</volume>
<fpage>1670</fpage>
<lpage>1676</lpage>
<pub-id pub-id-type="pmid">22124233</pub-id>
</element-citation>
</ref>
<ref id="R110">
<label>110</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dawlaty</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Ganz</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Markoulaki</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Page</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Jaenisch</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development</article-title>
<source/>Cell Stem Cell
          <year>2011</year>
<volume>9</volume>
<fpage>166</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="pmid">21816367</pub-id>
</element-citation>
</ref>
<ref id="R111">
<label>111</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Etchegaray</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Chavez</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>KN</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Martinez-Pastor</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Sommer</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Lienhard</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gladden</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kugel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Silberman</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Ramaswamy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mostoslavsky</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hochedlinger</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Goren</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The histone deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated production of 5-hydroxymethylcytosine</article-title>
<source/>Nat Cell Biol
          <year>2015</year>
<volume>17</volume>
<fpage>545</fpage>
<lpage>557</lpage>
<pub-id pub-id-type="pmid">25915124</pub-id>
</element-citation>
</ref>
<ref id="R112">
<label>112</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lienhard</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pastor</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Chawla</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Novotny</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tsagaratou</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lasken</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Surani</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Koralov</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Kalantry</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chavez</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Simultaneous deletion of the methylcytosine oxidases Tet1 and Tet3 increases transcriptome variability in early embryogenesis</article-title>
<source/>Proceedings of the National Academy of Sciences of the United States of America
          <year>2015</year>
<volume>112</volume>
<fpage>E4236</fpage>
<lpage>4245</lpage>
<pub-id pub-id-type="pmid">26199412</pub-id>
</element-citation>
</ref>
<ref id="R113">
<label>113</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dawlaty</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Breiling</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Barrasa</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Raddatz</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Faull</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Lyko</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Jaenisch</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Loss of Tet enzymes compromises proper differentiation of embryonic stem cells</article-title>
<source/>Developmental cell
          <year>2014</year>
<volume>29</volume>
<fpage>102</fpage>
<lpage>111</lpage>
<pub-id pub-id-type="pmid">24735881</pub-id>
</element-citation>
</ref>
<ref id="R114">
<label>114</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>SQ</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>FT</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Differential regulation of genomic imprinting by TET proteins in embryonic stem cells</article-title>
<source/>Stem Cell Res
          <year>2015</year>
<volume>15</volume>
<fpage>435</fpage>
<lpage>443</lpage>
<pub-id pub-id-type="pmid">26397890</pub-id>
</element-citation>
</ref>
<ref id="R115">
<label>115</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okashita</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kumaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ebi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nishi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nakayama</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sugasawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kojima</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Takada</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Okano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Seki</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>PRDM14 promotes active DNA demethylation through the Ten-eleven translocation (TET)-mediated base excision repair pathway in embryonic stem cells</article-title>
<source/>Development
          <year>2014</year>
<volume>141</volume>
<fpage>269</fpage>
<lpage>280</lpage>
<pub-id pub-id-type="pmid">24335252</pub-id>
</element-citation>
</ref>
<ref id="R116">
<label>116</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiquoine</surname>
<given-names>AD</given-names>
</name>
</person-group>
<article-title>The Identification, Origin, and Migration of the Primordial Germ Cells in the Mouse Embryo</article-title>
<source/>Anatomical Record
          <year>1954</year>
<volume>118</volume>
<fpage>135</fpage>
<lpage>146</lpage>
<pub-id pub-id-type="pmid">13138919</pub-id>
</element-citation>
</ref>
<ref id="R117">
<label>117</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ginsburg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Snow</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>McLaren</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Primordial germ cells in the mouse embryo during gastrulation</article-title>
<source/>Development
          <year>1990</year>
<volume>110</volume>
<fpage>521</fpage>
<lpage>528</lpage>
<pub-id pub-id-type="pmid">2133553</pub-id>
</element-citation>
</ref>
<ref id="R118">
<label>118</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>GQ</given-names>
</name>
<name>
<surname>Garbers</surname>
<given-names>DL</given-names>
</name>
</person-group>
<article-title>Male germ cell specification and differentiation</article-title>
<source/>Developmental Cell
          <year>2002</year>
<volume>2</volume>
<fpage>537</fpage>
<lpage>547</lpage>
<pub-id pub-id-type="pmid">12015962</pub-id>
</element-citation>
</ref>
<ref id="R119">
<label>119</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shamblott</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Axelman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bugg</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Littlefield</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Donovan</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Blumenthal</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Huggins</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Gearhart</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Derivation of pluripotent stem cells from cultured human primordial germ cells</article-title>
<source/>Proceedings of the National Academy of Sciences of the United States of America
          <year>1998</year>
<volume>95</volume>
<fpage>13726</fpage>
<lpage>13731</lpage>
<pub-id pub-id-type="pmid">9811868</pub-id>
</element-citation>
</ref>
<ref id="R120">
<label>120</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ono</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ogonuki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kohda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kaneko-Ishino</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ogura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ishino</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Erasing genomic imprinting memory in mouse clone embryos produced from day 11. 5 primordial germ cells</article-title>
<source/>Development
          <year>2002</year>
<volume>129</volume>
<fpage>1807</fpage>
<lpage>1817</lpage>
<pub-id pub-id-type="pmid">11934847</pub-id>
</element-citation>
</ref>
<ref id="R121">
<label>121</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamazaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>MRW</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Marh</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McCarrey</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Yanagimachi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bartolomei</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>Reprogramming of primordial germ cells begins before migration into the genital ridge, making these cells inadequate donors for reproductive cloning</article-title>
<source/>Proceedings of the National Academy of Sciences of the United States of America
          <year>2003</year>
<volume>100</volume>
<fpage>12207</fpage>
<lpage>12212</lpage>
<pub-id pub-id-type="pmid">14506296</pub-id>
</element-citation>
</ref>
<ref id="R122">
<label>122</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sasaki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Matsui</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Epigenetic events in mammalian germ-cell development: reprogramming and beyond</article-title>
<source/>Nature reviews Genetics
          <year>2008</year>
<volume>9</volume>
<fpage>129</fpage>
<lpage>140</lpage>
</element-citation>
</ref>
<ref id="R123">
<label>123</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saitou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kagiwada</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kurimoto</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Epigenetic reprogramming in mouse pre-implantation development and primordial germ cells</article-title>
<source/>Development
          <year>2012</year>
<volume>139</volume>
<fpage>15</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="pmid">22147951</pub-id>
</element-citation>
</ref>
<ref id="R124">
<label>124</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smallwood</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Kelsey</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>De novo DNA methylation: a germ cell perspective</article-title>
<source/>Trends Genet
          <year>2012</year>
<volume>28</volume>
<fpage>33</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="pmid">22019337</pub-id>
</element-citation>
</ref>
<ref id="R125">
<label>125</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamaguchi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Diep</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>5mC and 5hmC dynamics during PGC reprogramming and role of Tet1 in female meiosis</article-title>
<source/>Epigenetics &amp; Chromatin
          <year>2013</year>
<volume>6</volume>
<fpage>P89</fpage>
</element-citation>
</ref>
<ref id="R126">
<label>126</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vincent</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>P-Y</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Calvopina</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Nee</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Faull</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Pellegrini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>AT</given-names>
</name>
</person-group>
<article-title>Stage-specific roles for tet1 and tet2 in DNA demethylation in primordial germ cells</article-title>
<source/>Cell stem cell
          <year>2013</year>
<volume>12</volume>
<fpage>470</fpage>
<lpage>478</lpage>
<pub-id pub-id-type="pmid">23415914</pub-id>
</element-citation>
</ref>
<ref id="R127">
<label>127</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hajkova</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Jeffries</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Surani</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Genome-wide reprogramming in the mouse germ line entails the base excision repair pathway</article-title>
<source/>Science
          <year>2010</year>
<volume>329</volume>
<fpage>78</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="pmid">20595612</pub-id>
</element-citation>
</ref>
<ref id="R128">
<label>128</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Popp</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Cokus</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Andrews</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pellegrini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Reik</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency</article-title>
<source/>Nature
          <year>2010</year>
<volume>463</volume>
<fpage>1101</fpage>
<lpage>U1126</lpage>
<pub-id pub-id-type="pmid">20098412</pub-id>
</element-citation>
</ref>
<ref id="R129">
<label>129</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calvopina</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Nee</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>AT</given-names>
</name>
</person-group>
<article-title>The Aorta-Gonad-Mesonephros Organ Culture Recapitulates 5hmC Reorganization and Replication-Dependent and Independent Loss of DNA Methylation in the Germline</article-title>
<source/>Stem Cells Dev
          <year>2015</year>
<volume>24</volume>
<fpage>1536</fpage>
<lpage>1545</lpage>
<pub-id pub-id-type="pmid">25749005</pub-id>
</element-citation>
</ref>
<ref id="R130">
<label>130</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>The role of DNA methylation in the central nervous system and neuropsychiatric disorders</article-title>
<source/>International review of neurobiology
          <year>2009</year>
<volume>89</volume>
<fpage>67</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="pmid">19900616</pub-id>
</element-citation>
</ref>
<ref id="R131">
<label>131</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teter</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Rozovsky</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Krohn</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Osterburg</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Finch</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Methylation of the glial fibrillary acidic protein gene shows novel biphasic changes during brain development</article-title>
<source/>Glia
          <year>1996</year>
<volume>17</volume>
<fpage>195</fpage>
<lpage>205</lpage>
<pub-id pub-id-type="pmid">8840161</pub-id>
</element-citation>
</ref>
<ref id="R132">
<label>132</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devlin</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Brain</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Austin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Oberlander</surname>
<given-names>TF</given-names>
</name>
</person-group>
<article-title>Prenatal exposure to maternal depressed mood and the MTHFR C677T variant affect SLC6A4 methylation in infants at birth</article-title>
<source/>PLoS ONE
          <year>2010</year>
<volume>5</volume>
<fpage>e12201</fpage>
<pub-id pub-id-type="pmid">20808944</pub-id>
</element-citation>
</ref>
<ref id="R133">
<label>133</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>JJU</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>DKK</given-names>
</name>
<name>
<surname>Mo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Bonaguidi</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Balazer</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Eaves</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ford</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ming</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>HJ</given-names>
</name>
</person-group>
<article-title>Neuronal activity modifies the DNA methylation landscape in the adult brain</article-title>
<source/>Nature Neuroscience
          <year>2011</year>
<volume>14</volume>
<fpage>1345</fpage>
<lpage>U1172</lpage>
<pub-id pub-id-type="pmid">21874013</pub-id>
</element-citation>
</ref>
<ref id="R134">
<label>134</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costello</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>DNA methylation in brain development and gliomagenesis</article-title>
<source/>Frontiers in Bioscience
          <year>2003</year>
<volume>8</volume>
<fpage>S175</fpage>
<lpage>S184</lpage>
<pub-id pub-id-type="pmid">12456310</pub-id>
</element-citation>
</ref>
<ref id="R135">
<label>135</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawai</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hirotsune</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hirose</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fushiki</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hayashizaki</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Methylation Profiles of Genomic DNA of Mouse Developmental Brain Detected by Restriction Landmark Genomic Scanning (Rlgs) Method</article-title>
<source/>Nucleic Acids Research
          <year>1993</year>
<volume>21</volume>
<fpage>5604</fpage>
<lpage>5608</lpage>
<pub-id pub-id-type="pmid">8284204</pub-id>
</element-citation>
</ref>
<ref id="R136">
<label>136</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fuchikami</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Morinobu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Segawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yamawaki</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ozaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kusumi</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Koyama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tsuchiyama</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Terao</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression</article-title>
<source/>PLoS One
          <year>2011</year>
<volume>6</volume>
<fpage>e23881</fpage>
<pub-id pub-id-type="pmid">21912609</pub-id>
</element-citation>
</ref>
<ref id="R137">
<label>137</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hutnick</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Golshani</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Namihira</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>ZG</given-names>
</name>
<name>
<surname>Matynia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>XW</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Schweizer</surname>
<given-names>FE</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>GP</given-names>
</name>
</person-group>
<article-title>DNA hypomethylation restricted to the murine forebrain induces cortical degeneration and impairs postnatal neuronal maturation</article-title>
<source/>Human Molecular Genetics
          <year>2009</year>
<volume>18</volume>
<fpage>2875</fpage>
<lpage>2888</lpage>
<pub-id pub-id-type="pmid">19433415</pub-id>
</element-citation>
</ref>
<ref id="R138">
<label>138</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Coskun</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Yoshikawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>YE</given-names>
</name>
</person-group>
<article-title>Dnmt3a-Dependent Nonpromoter DNA Methylation Facilitates Transcription of Neurogenic Genes</article-title>
<source/>Science
          <year>2010</year>
<volume>329</volume>
<fpage>444</fpage>
<lpage>448</lpage>
<pub-id pub-id-type="pmid">20651149</pub-id>
</element-citation>
</ref>
<ref id="R139">
<label>139</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kriaucionis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Heintz</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain</article-title>
<source/>Science
          <year>2009</year>
<volume>324</volume>
<fpage>929</fpage>
<lpage>930</lpage>
<pub-id pub-id-type="pmid">19372393</pub-id>
</element-citation>
</ref>
<ref id="R140">
<label>140</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kriaucionis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Heintz</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain</article-title>
<source/>Science
          <year>2009</year>
<volume>324</volume>
<fpage>929</fpage>
<lpage>930</lpage>
<pub-id pub-id-type="pmid">19372393</pub-id>
</element-citation>
</ref>
<ref id="R141">
<label>141</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gross</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Pacis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Barreiro</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Ernst</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Turecki</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Characterizing 5-hydroxymethylcytosine in human prefrontal cortex at single base resolution</article-title>
<source/>BMC genomics
          <year>2015</year>
<volume>16</volume>
<fpage>672</fpage>
<pub-id pub-id-type="pmid">26334641</pub-id>
</element-citation>
</ref>
<ref id="R142">
<label>142</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>JU</given-names>
</name>
<name>
<surname>Szulwach</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ming</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Genome-wide antagonism between 5-hydroxymethylcytosine and DNA methylation in the adult mouse brain</article-title>
<source/>Front Biol (Beijing)
          <year>2014</year>
<volume>9</volume>
<fpage>66</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="pmid">25568643</pub-id>
</element-citation>
</ref>
<ref id="R143">
<label>143</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>XW</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>AX</given-names>
</name>
<name>
<surname>Pfeifer</surname>
<given-names>GP</given-names>
</name>
</person-group>
<article-title>Genomic mapping of 5-hydroxymethylcytosine in the human brain</article-title>
<source/>Nucleic Acids Research
          <year>2011</year>
<volume>39</volume>
<fpage>5015</fpage>
<lpage>5024</lpage>
<pub-id pub-id-type="pmid">21378125</pub-id>
</element-citation>
</ref>
<ref id="R144">
<label>144</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Spatial distribution of 5-hydroxymethyl cytosine in rat brain and temporal distribution in striatum</article-title>
<source/>Neurochemical research
          <year>2015</year>
<volume>40</volume>
<fpage>688</fpage>
<lpage>697</lpage>
<pub-id pub-id-type="pmid">25645445</pub-id>
</element-citation>
</ref>
<ref id="R145">
<label>145</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Szulwach</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>C-X</given-names>
</name>
<name>
<surname>He</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Genome-wide DNA hydroxymethylation changes are associated with neurodevelopmental genes in the developing human cerebellum</article-title>
<source/>Human molecular genetics
          <year>2012</year>
<volume>21</volume>
<fpage>5500</fpage>
<lpage>5510</lpage>
<pub-id pub-id-type="pmid">23042784</pub-id>
</element-citation>
</ref>
<ref id="R146">
<label>146</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>QY</given-names>
</name>
<name>
<surname>Murai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>ZD</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rosa</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YK</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>HP</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>ZM</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>YQ</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>Meissner</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tet1 Regulates Adult Hippocampal Neurogenesis and Cognition</article-title>
<source/>Cell Stem Cell
          <year>2013</year>
<volume>13</volume>
<fpage>237</fpage>
<lpage>245</lpage>
<pub-id pub-id-type="pmid">23770080</pub-id>
</element-citation>
</ref>
<ref id="R147">
<label>147</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colquitt</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>WE</given-names>
</name>
<name>
<surname>Barnea</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lomvardas</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Alteration of genic 5-hydroxymethylcytosine patterning in olfactory neurons correlates with changes in gene expression and cell identity</article-title>
<source/>Proceedings of the National Academy of Sciences of the United States of America
          <year>2013</year>
<volume>110</volume>
<fpage>14682</fpage>
<lpage>14687</lpage>
<pub-id pub-id-type="pmid">23969834</pub-id>
</element-citation>
</ref>
<ref id="R148">
<label>148</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bose</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Spulber</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kilian</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Heldring</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lonnerberg</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Johnsson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hermanson</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Ceccatelli</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Tet3 mediates stable glucocorticoid-induced alterations in DNA methylation and Dnmt3a/Dkk1 expression in neural progenitors</article-title>
<source/>Cell Death Dis
          <year>2015</year>
<volume>6</volume>
<fpage>e1793</fpage>
<pub-id pub-id-type="pmid">26086966</pub-id>
</element-citation>
</ref>
<ref id="R149">
<label>149</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dzitoyeva</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Manev</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Effect of aging on 5-hydroxymethylcytosine in brain mitochondria</article-title>
<source/>Neurobiology of Aging
          <year>2012</year>
<volume>33</volume>
<fpage>2881</fpage>
<lpage>2891</lpage>
<pub-id pub-id-type="pmid">22445327</pub-id>
</element-citation>
</ref>
<ref id="R150">
<label>150</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>X-B</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S-Y</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>S-H</given-names>
</name>
<name>
<surname>Rhee</surname>
<given-names>Y-H</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E-H</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>C-H</given-names>
</name>
<name>
<surname>Dixit</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>FE</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S-H</given-names>
</name>
</person-group>
<article-title>Vitamin C facilitates dopamine neuron differentiation in fetal midbrain through TET1- and JMJD3-dependent epigenetic control manner</article-title>
<source/>Stem cells
          <year>2015</year>
<volume>33</volume>
<fpage>1320</fpage>
<lpage>1332</lpage>
<pub-id pub-id-type="pmid">25535150</pub-id>
</element-citation>
</ref>
<ref id="R151">
<label>151</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J-Q</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y-S</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>Y-Q</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y-G</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>H-R</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>T-S</given-names>
</name>
</person-group>
<article-title>Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease</article-title>
<source/>Human molecular genetics
          <year>2013</year>
<volume>22</volume>
<fpage>3641</fpage>
<lpage>3653</lpage>
<pub-id pub-id-type="pmid">23669348</pub-id>
</element-citation>
</ref>
<ref id="R152">
<label>152</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coppieters</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Dieriks</surname>
<given-names>BV</given-names>
</name>
<name>
<surname>Lill</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Faull</surname>
<given-names>RLM</given-names>
</name>
<name>
<surname>Curtis</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Dragunow</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain</article-title>
<source/>Neurobiology of aging
          <year>2014</year>
<volume>35</volume>
<fpage>1334</fpage>
<lpage>1344</lpage>
<pub-id pub-id-type="pmid">24387984</pub-id>
</element-citation>
</ref>
<ref id="R153">
<label>153</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhubi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Guidotti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Grayson</surname>
<given-names>DR</given-names>
</name>
</person-group>
<article-title>Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum</article-title>
<source/>Translational psychiatry
          <year>2014</year>
<volume>4</volume>
<fpage>e349</fpage>
<pub-id pub-id-type="pmid">24448211</pub-id>
</element-citation>
</ref>
<ref id="R154">
<label>154</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dzitoyeva</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Matrisciano</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Tueting</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Grayson</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Guidotti</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Brain-Derived Neurotrophic Factor Epigenetic Modifications Associated with Schizophrenia-like Phenotype Induced by Prenatal Stress in Mice</article-title>
<source/>Biological psychiatry
          <year>2015</year>
<volume>77</volume>
<fpage>589</fpage>
<lpage>596</lpage>
<pub-id pub-id-type="pmid">25444166</pub-id>
</element-citation>
</ref>
<ref id="R155">
<label>155</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greco</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kunderfranco</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Carullo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Papait</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Condorelli</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>P356Dynamic nature of the methylation landscape of the heart</article-title>
<source/>Cardiovascular Research
          <year>2014</year>
<volume>103</volume>
<fpage>S65</fpage>
<lpage>S65</lpage>
</element-citation>
</ref>
<ref id="R156">
<label>156</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Terragni</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Pradhan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Lacey</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ehrlich</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Notch signaling genes: myogenic DNA hypomethylation and 5-hydroxymethylcytosine</article-title>
<source/>Epigenetics
          <year>2014</year>
<volume>9</volume>
<fpage>842</fpage>
<lpage>850</lpage>
<pub-id pub-id-type="pmid">24670287</pub-id>
</element-citation>
</ref>
<ref id="R157">
<label>157</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wendler</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Poulsen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Caffeine induces both short-term and long-term effects on gene expression and DNA methylation in the mouse heart (542.3)</article-title>
<source/>The FASEB Journal
          <year>2014</year>
<volume>28</volume>
<issue>1 Supplement</issue>
<fpage>542</fpage>
<lpage>543</lpage>
</element-citation>
</ref>
<ref id="R158">
<label>158</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang-Hu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Rivkees</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Wendler</surname>
<given-names>CC</given-names>
</name>
</person-group>
<article-title>cAMP induces hypertrophy and alters DNA methylation in HL-1 cardiomyocytes</article-title>
<source/>American Journal of Physiology - Cell Physiology
          <year>2015</year>
<volume>309</volume>
<fpage>C425</fpage>
<lpage>C436</lpage>
<pub-id pub-id-type="pmid">26224577</pub-id>
</element-citation>
</ref>
<ref id="R159">
<label>159</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tellides</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hwa</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>KA</given-names>
</name>
</person-group>
<article-title>Ten-eleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity</article-title>
<source/>Circulation
          <year>2013</year>
<volume>128</volume>
<fpage>2047</fpage>
<lpage>2057</lpage>
<pub-id pub-id-type="pmid">24077167</pub-id>
</element-citation>
</ref>
<ref id="R160">
<label>160</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiou</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>WI</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic</article-title>
<source/>Stroke
          <year>1997</year>
<volume>28</volume>
<fpage>1717</fpage>
<lpage>1723</lpage>
<pub-id pub-id-type="pmid">9303014</pub-id>
</element-citation>
</ref>
<ref id="R161">
<label>161</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Effects of arsenic trioxide on proliferation, paracrine and migration of cardiac progenitor cells</article-title>
<source/>International journal of cardiology
          <year>2015</year>
<volume>179</volume>
<fpage>393</fpage>
<lpage>396</lpage>
<pub-id pub-id-type="pmid">25464494</pub-id>
</element-citation>
</ref>
<ref id="R162">
<label>162</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Qiao</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Arsenic-induced interstitial myocardial fibrosis reveals a new insight into drug-induced long QT syndrome</article-title>
<source/>Cardiovascular research
          <year>2012</year>
<volume>96</volume>
<fpage>90</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="pmid">22853924</pub-id>
</element-citation>
</ref>
<ref id="R163">
<label>163</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Alamdar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Exposure to arsenic via drinking water induces 5-hydroxymethylcytosine alteration in rat</article-title>
<source/>The Science of the total environment
          <year>2014</year>
<volume>497-498</volume>
<fpage>618</fpage>
<lpage>625</lpage>
<pub-id pub-id-type="pmid">25256144</pub-id>
</element-citation>
</ref>
<ref id="R164">
<label>164</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Amato</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Arsenite Targets the Zinc Finger Domains of Tet Proteins and Inhibits Tet-Mediated Oxidation of 5-Methylcytosine</article-title>
<source/>Environ Sci Technol
          <year>2015</year>
<volume>49</volume>
<issue>19</issue>
<fpage>11923</fpage>
<lpage>11931</lpage>
<pub-id pub-id-type="pmid">26355596</pub-id>
</element-citation>
</ref>
<ref id="R165">
<label>165</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy</article-title>
<source/>Current Genomics
          <year>2009</year>
<volume>10</volume>
<fpage>336</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="pmid">20119531</pub-id>
</element-citation>
</ref>
<ref id="R166">
<label>166</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Ou</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Yen</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Global DNA methylation, DNMT1, and MBD2 in patients with rheumatoid arthritis</article-title>
<source/>Immunol Lett
          <year>2011</year>
<volume>135</volume>
<fpage>96</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="pmid">20937307</pub-id>
</element-citation>
</ref>
<ref id="R167">
<label>167</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>PY</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>MF</given-names>
</name>
</person-group>
<article-title>Expression and function role of DNA methyltransferase 1 in human bladder cancer</article-title>
<source/>Cancer
          <year>2011</year>
<volume>117</volume>
<fpage>5221</fpage>
<lpage>5233</lpage>
<pub-id pub-id-type="pmid">21523767</pub-id>
</element-citation>
</ref>
<ref id="R168">
<label>168</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okamura</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Matsuda</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ishikawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tanae</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kohri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kawai</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Asou</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bessho</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Hematologic improvements in a myelodysplastic syndromes with myelofibrosis (MDS-F) patient treated with azacitidine</article-title>
<source/>Leuk Res Rep
          <year>2014</year>
<volume>3</volume>
<fpage>24</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmid">24809010</pub-id>
</element-citation>
</ref>
<ref id="R169">
<label>169</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steensma</surname>
<given-names>DP</given-names>
</name>
</person-group>
<article-title>Decitabine treatment of patients with higher-risk myelodysplastic syndromes</article-title>
<source/>Leuk Res
          <year>2009</year>
<volume>33</volume>
<issue>Suppl 2</issue>
<fpage>S12</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="pmid">20004791</pub-id>
</element-citation>
</ref>
<ref id="R170">
<label>170</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Claxton</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Erba</surname>
<given-names>HP</given-names>
</name>
<name>
<surname>Faderl</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Arellano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lyons</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Kovacsovics</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gabrilove</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Huebner</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gandhi</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Kantarjian</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemia</article-title>
<source/>Leuk Lymphoma
          <year>2012</year>
<volume>53</volume>
<fpage>435</fpage>
<lpage>440</lpage>
<pub-id pub-id-type="pmid">21877883</pub-id>
</element-citation>
</ref>
<ref id="R171">
<label>171</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaminskas</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Farrell</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Sridhara</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pazdur</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspension</article-title>
<source/>Oncologist
          <year>2005</year>
<volume>10</volume>
<fpage>176</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="pmid">15793220</pub-id>
</element-citation>
</ref>
<ref id="R172">
<label>172</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huls</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Azacitidine in AML: a treatment option?</article-title>
<source/>Blood
          <year>2015</year>
<volume>126</volume>
<fpage>283</fpage>
<lpage>284</lpage>
<pub-id pub-id-type="pmid">26185114</pub-id>
</element-citation>
</ref>
<ref id="R173">
<label>173</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hahn</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Bonney</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Dhawan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Balch</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Hartman-Frey</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Ostrander</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Nephew</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Knapp</surname>
<given-names>DW</given-names>
</name>
</person-group>
<article-title>Subcutaneous 5-azacitidine treatment of naturally occurring canine urothelial carcinoma: a novel epigenetic approach to human urothelial carcinoma drug development</article-title>
<source/>J Urol
          <year>2012</year>
<volume>187</volume>
<fpage>302</fpage>
<lpage>309</lpage>
<pub-id pub-id-type="pmid">22099988</pub-id>
</element-citation>
</ref>
<ref id="R174">
<label>174</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schneider-Stock</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Diab-Assef</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rohrbeck</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Foltzer-Jourdainne</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Boltze</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hartig</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schönfeld</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Roessner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gali-Muhtasib</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms</article-title>
<source/>J Pharmacol Exp Ther
          <year>2005</year>
<volume>312</volume>
<fpage>525</fpage>
<lpage>536</lpage>
<pub-id pub-id-type="pmid">15547111</pub-id>
</element-citation>
</ref>
<ref id="R175">
<label>175</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyoshi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fujii</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ueda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Towata</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Fusamoto</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kamada</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Taniguchi</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Enhancement of hepatitis-B surface-antigen expression by 5-azacytidine in a hepatitis-B-virus-transfected cell line</article-title>
<source/>Int J Cancer
          <year>1992</year>
<volume>52</volume>
<fpage>137</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="pmid">1379994</pub-id>
</element-citation>
</ref>
<ref id="R176">
<label>176</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christman</surname>
<given-names>JK</given-names>
</name>
</person-group>
<article-title>5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy</article-title>
<source/>Oncogene
          <year>2002</year>
<volume>21</volume>
<fpage>5483</fpage>
<lpage>5495</lpage>
<pub-id pub-id-type="pmid">12154409</pub-id>
</element-citation>
</ref>
<ref id="R177">
<label>177</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malik</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cashen</surname>
<given-names>AF</given-names>
</name>
</person-group>
<article-title>Decitabine in the treatment of acute myeloid leukemia in elderly patients</article-title>
<source/>Cancer Manag Res
          <year>2014</year>
<volume>6</volume>
<fpage>53</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="pmid">24520204</pub-id>
</element-citation>
</ref>
<ref id="R178">
<label>178</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kantarjian</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Issa</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Albitar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>DiPersio</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Klimek</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Slack</surname>
<given-names>J</given-names>
</name>
<name>
<surname>de Castro</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ravandi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Helmer</surname>
<given-names>R</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Shen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Nimer</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Leavitt</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Raza</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Saba</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study</article-title>
<source/>Cancer
          <year>2006</year>
<volume>106</volume>
<fpage>1794</fpage>
<lpage>1803</lpage>
<pub-id pub-id-type="pmid">16532500</pub-id>
</element-citation>
</ref>
<ref id="R179">
<label>179</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Momparler</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Bouffard</surname>
<given-names>DY</given-names>
</name>
<name>
<surname>Momparler</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Dionne</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Belanger</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ayoub</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Pilot phase I-II study on 5-aza-2′-deoxycytidine (Decitabine) in patients with metastatic lung cancer</article-title>
<source/>Anticancer Drugs
          <year>1997</year>
<volume>8</volume>
<fpage>358</fpage>
<lpage>368</lpage>
<pub-id pub-id-type="pmid">9180389</pub-id>
</element-citation>
</ref>
<ref id="R180">
<label>180</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ritchie</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Feldman</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Christos</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Rohan</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Lagassa</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Ippoliti</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Scandura</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Carlson</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Roboz</surname>
<given-names>GJ</given-names>
</name>
</person-group>
<article-title>Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia</article-title>
<source/>Leuk Lymphoma
          <year>2013</year>
<volume>54</volume>
<fpage>2003</fpage>
<lpage>2007</lpage>
<pub-id pub-id-type="pmid">23270581</pub-id>
</element-citation>
</ref>
<ref id="R181">
<label>181</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagasawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Raghunath</surname>
<given-names>PN</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>El-Salem</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Szallasi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Marzec</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gimotty</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rook</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Vonderheid</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Odum</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wasik</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing</article-title>
<source/>Leuk Res
          <year>2006</year>
<volume>30</volume>
<fpage>303</fpage>
<lpage>312</lpage>
<pub-id pub-id-type="pmid">16185764</pub-id>
</element-citation>
</ref>
<ref id="R182">
<label>182</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lemaire</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Momparler</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Raynal</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Bernstein</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Momparler</surname>
<given-names>RL</given-names>
</name>
</person-group>
<article-title>Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2′-deoxycytidine</article-title>
<source/>Cancer Chemother Pharmacol
          <year>2009</year>
<volume>63</volume>
<fpage>411</fpage>
<lpage>416</lpage>
<pub-id pub-id-type="pmid">18398609</pub-id>
</element-citation>
</ref>
<ref id="R183">
<label>183</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Connolly</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Dickman</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Hurd</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Hornby</surname>
<given-names>DP</given-names>
</name>
</person-group>
<article-title>Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases</article-title>
<source/>J Mol Biol
          <year>2002</year>
<volume>321</volume>
<fpage>591</fpage>
<lpage>599</lpage>
<pub-id pub-id-type="pmid">12206775</pub-id>
</element-citation>
</ref>
<ref id="R184">
<label>184</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Weisenberger</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Chuang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wozniak</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Marquez</surname>
<given-names>VE</given-names>
</name>
<name>
<surname>Greer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Orntoft</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Thykjaer</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>PA</given-names>
</name>
</person-group>
<article-title>Preferential response of cancer cells to zebularine</article-title>
<source/>Cancer Cell
          <year>2004</year>
<volume>6</volume>
<fpage>151</fpage>
<lpage>158</lpage>
<pub-id pub-id-type="pmid">15324698</pub-id>
</element-citation>
</ref>
<ref id="R185">
<label>185</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xue</surname>
<given-names>ZT</given-names>
</name>
<name>
<surname>Sjögren</surname>
<given-names>HO</given-names>
</name>
<name>
<surname>Salford</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Widegren</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>An epigenetic mechanism for high, synergistic expression of indoleamine 2,3-dioxygenase 1 (IDO1) by combined treatment with zebularine and IFN-gamma: potential therapeutic use in autoimmune diseases</article-title>
<source/>Molecular Immunology
          <year>2012</year>
<volume>51</volume>
<fpage>101</fpage>
<lpage>111</lpage>
<pub-id pub-id-type="pmid">22424783</pub-id>
</element-citation>
</ref>
<ref id="R186">
<label>186</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naeem</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gul</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Salim</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Abstract 15368: Zebularine Enhances Cardiomyogenic Differentiation Potential of both Mesenchymal Stem Cells and Mature Fibroblasts</article-title>
<source/>Circulation
          <year>2014</year>
<volume>130</volume>
<fpage>A15368</fpage>
</element-citation>
</ref>
<ref id="R187">
<label>187</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lech-Maranda</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Korycka</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Robak</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity</article-title>
<source/>Mini Rev Med Chem
          <year>2009</year>
<volume>9</volume>
<fpage>805</fpage>
<lpage>812</lpage>
<pub-id pub-id-type="pmid">19519505</pub-id>
</element-citation>
</ref>
<ref id="R188">
<label>188</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonate</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Arthaud</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cantrell</surname>
<given-names>WR</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Stephenson</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Secrist</surname>
<given-names>JA</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Weitman</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Discovery and development of clofarabine: a nucleoside analogue for treating cancer</article-title>
<source/>Nat Rev Drug Discov
          <year>2006</year>
<volume>5</volume>
<fpage>855</fpage>
<lpage>863</lpage>
<pub-id pub-id-type="pmid">17016426</pub-id>
</element-citation>
</ref>
<ref id="R189">
<label>189</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shahriar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>SU</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>SH</given-names>
</name>
</person-group>
<article-title>Clofarabine induces hypomethylation of DNA and expression of Cancer-Testis antigens</article-title>
<source/>Leuk Res
          <year>2009</year>
<volume>33</volume>
<fpage>1678</fpage>
<lpage>1683</lpage>
<pub-id pub-id-type="pmid">19427036</pub-id>
</element-citation>
</ref>
<ref id="R190">
<label>190</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stumpel</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Pieters</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Stam</surname>
<given-names>RW</given-names>
</name>
</person-group>
<article-title>The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia</article-title>
<source/>Eur J Cancer
          <year>2015</year>
<volume>51</volume>
<fpage>2008</fpage>
<lpage>2021</lpage>
<pub-id pub-id-type="pmid">26188848</pub-id>
</element-citation>
</ref>
<ref id="R191">
<label>191</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klisovic</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Stock</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Cataland</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Klisovic</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Blum</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Odenike</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Godley</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Burgt</surname>
<given-names>JV</given-names>
</name>
<name>
<surname>Van Laar</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cullen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Macleod</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Besterman</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Byrd</surname>
<given-names>JC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemia</article-title>
<source/>Clin Cancer Res
          <year>2008</year>
<volume>14</volume>
<fpage>2444</fpage>
<lpage>2449</lpage>
<pub-id pub-id-type="pmid">18413836</pub-id>
</element-citation>
</ref>
<ref id="R192">
<label>192</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amato</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Stephenson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hotte</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nemunaitis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Belanger</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Martell</surname>
<given-names>RE</given-names>
</name>
</person-group>
<article-title>MG98, a second-generation DNMT1 inhibitor, in the treatment of advanced renal cell carcinoma</article-title>
<source/>Cancer Invest
          <year>2012</year>
<volume>30</volume>
<fpage>415</fpage>
<lpage>421</lpage>
<pub-id pub-id-type="pmid">22571342</pub-id>
</element-citation>
</ref>
<ref id="R193">
<label>193</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brueckner</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Garcia Boy</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Siedlecki</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Musch</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kliem</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Zielenkiewicz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Suhai</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wiessler</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lyko</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases</article-title>
<source/>Cancer Res
          <year>2005</year>
<volume>65</volume>
<fpage>6305</fpage>
<lpage>6311</lpage>
<pub-id pub-id-type="pmid">16024632</pub-id>
</element-citation>
</ref>
<ref id="R194">
<label>194</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Savickiene</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Treigyte</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jazdauskaite</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Borutinskaite</surname>
<given-names>VV</given-names>
</name>
<name>
<surname>Navakauskiene</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>DNA methyltransferase inhibitor RG108 and histone deacetylase inhibitors cooperate to enhance NB4 cell differentiation and E-cadherin re-expression by chromatin remodelling</article-title>
<source/>Cell Biol Int
          <year>2012</year>
<volume>36</volume>
<fpage>1067</fpage>
<lpage>1078</lpage>
<pub-id pub-id-type="pmid">22845560</pub-id>
</element-citation>
</ref>
<ref id="R195">
<label>195</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oh</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>GW</given-names>
</name>
</person-group>
<article-title>Anti-senescence effects of DNA methyltransferase inhibitor RG108 in human bone marrow mesenchymal stromal cells</article-title>
<source/>Biotechnol Appl Biochem
          <year>2015</year>
<volume>62</volume>
<fpage>583</fpage>
<lpage>590</lpage>
<pub-id pub-id-type="pmid">25952632</pub-id>
</element-citation>
</ref>
<ref id="R196">
<label>196</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blaschke</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ebata</surname>
<given-names>KT</given-names>
</name>
<name>
<surname>Karimi</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Zepeda-Martinez</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Goyal</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mahapatra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Laird</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Hirst</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lorincz</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Ramalho-Santos</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells</article-title>
<source/>Nature
          <year>2013</year>
<volume>500</volume>
<fpage>222</fpage>
<lpage>226</lpage>
<pub-id pub-id-type="pmid">23812591</pub-id>
</element-citation>
</ref>
<ref id="R197">
<label>197</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>WY</given-names>
</name>
<name>
<surname>He</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Vitamin C protects against UV irradiation-induced apoptosis through reactivating silenced tumor suppressor genes p21 and p16 in a Tet-dependent DNA demethylation manner in human skin cancer cells</article-title>
<source/>Cancer Biother Radiopharm
          <year>2014</year>
<volume>29</volume>
<fpage>257</fpage>
<lpage>264</lpage>
<pub-id pub-id-type="pmid">25003799</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>